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 CLINICAL SIGNIFICANCE OF RED CELL DISTRIBUTION WIDTH 
(RDW) AND CIRCULATING NEUTROPHIL - LYMPHOCYTE COUNT 
RATIO (NLCR) AS PROGNOSTIC MARKERS IN SEPSIS 
 
ABSTRACT 
 
BACKGROUND 
       Sepsis and septic shock are one of the leading causes of death worldwide. 
Rapid and precise diagnosis and appropriate antibiotic therapy is necessary to reduce 
mortality and morbidity in patients with sepsis. Though several biomarkers and scoring 
systems have been evaluated, prognostic markers to quickly and precisely establish the 
diagnosis or prognosis of patients with sepsis and septic shock are yet to be evaluated. 
Hence this study is being done to assess the efficiency of the haemogram parameters 
RDW and NLCR as biomarkers in predicting the clinical outcome of patients with sepsis, 
severe sepsis and septic shock and to study the correlation of RDW and NLCR with 
SOFA score. 
METHODOLOGY 
In this prospective observational study, 85 adult patients of both sex with a 
diagnosis of sepsis and admitted in the emergency wards and Intensive medical Care unit 
between April 2017 and September 2017 in the Stanley Medical college Hospital, 
Chennai were included. The source of infection, complications, duration of in-hospital 
stay, RDW and NLCR were compared between the survivors and non-survivors groups. 
RESULTS 
The male-female ratio was 59.42:40.58. Females showed a high rate of mortality. 
The occurrence of comorbid conditions like Diabetic mellitus, Hypertension and 
 Chronic kidney disease showed higher risk of death outcome. Mean RDW was 
16.22±0.89 in the case of survivors and 19.08±1.04 in the case of non-survivors which 
was statistically significant (p<0.0001) with respect to duration of stay and need for 
inotropic support. The mean NLCR was 8.95±1.54 in survivors and 13.24±1.37 in non-
survivors, the results are statistically significant (p<0.0001). A highly significant and 
positive correlation of RDW and NLCR with SOFA score was observed. 
CONCLUSION 
 RDW and NLCR measured on admission can be used as prognostic markers in 
patients with sepsis, severe sepsis and septic shock. 
KEYWORDS: 
Sepsis, septic shock, prognostic markers, RDW, NLCR, SOFA Score. 
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INTRODUCTION 
 
Sepsis is a clinical syndrome characterized by systemic inflammation due to 
infection, the severity ranging from sepsis to septic shock. Data from the centre for 
Disease Control and Prevention reveals that sepsis is the leading cause of death in non-
coronary intensive care unit patients and the tenth most common cause of death 
worldwide, the first being heart disease.
1
 Despite advances in intensive care and 
antimicrobial therapy, the incidence of sepsis and related mortality rate has increased 
over the last thirty years.
2 
The mortality rate is estimated at 30% in sepsis and 80% in 
septic shock in the USA
 3
 and at 12.8% in sepsis and 45.7% in septic shock in Europe.
4 
Reduced rates of reporting may affect estimations in developing countries.  
Sepsis or severe sepsis is defined as the harmful systemic response (including 
some degree of hypofunction) with the proven or suspected microbial etiology. Septic 
shock is sepsis with hypotension (arterial blood pressure < 90 mmHg below patient’s 
normal blood pressure for at least one hour despite fluid resuscitation) or need for 
vasopressors to maintain the systolic blood pressure ≥ 90 mmHg or mean arterial blood 
pressure ≥70 mmHg. The incidence of sepsis and septic shock continues to increase 
worldwide. The mortality increase has been attributable to patients’ advanced age, 
preexisting comorbidity, immunosuppressive diseases and therapies or infections with 
multi-drug resistant bacteria, patients with chronic diseases for a long period, and those 
on medical treatment that circumvent host defenses viz. in-dwelling catheters and 
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mechanical devices.
5 
Invasive bacterial infections are a prominent cause of death around 
the world-especially among children. 
Without consistent and reproducible criteria the extensive pathophysiology 
associated with sepsis is difficult to diagnose and treat. A delay in the diagnosis and 
treatment of sepsis will result in the rapid progression of circulatory failure, multiple 
organ dysfunction and eventually death.
6 
 
Treatment guidelines are ambiguous. It involves a prolonged hospital stay for 
patients, while receiving complex therapy. The in-hospital mortality risk of 10% in 
patients diagnosed with sepsis is widespread and those who develop septic shock 
increase  their mortality risk greater than 40%.
7
 
 Early diagnosis of severity of sepsis and appropriate treatment is essential for the 
survival of the patients. There are many biochemical markers, clinical parameters and 
scoring systems used to assess the severity and in predicting the mortality in patients with 
sepsis- some of which include- estimating serum  procalcitonin levels, clinical scoring 
systems like Sequential Organ Failure Assessment (SOFA), quick SOFA (qSOFA), 
Acute Physiology and Chronic Health Evaluation (APACHE II) scoring systems. The 
degree of severity is most often quantified by the Sequential Organ Failure Assessment 
(SOFA) score, which can predict the severity and outcome of multiple organ failure. 
However, calculating SOFA score is cumbersome. Moreover, assessment of the septic 
patient outcome during treatment needs to be focused on, as currently used clinical and 
biological criteria are undefined and inadequate for this purpose.  
3 
 
The need for simple, cost effective and easily available, yet reliable markers has 
pushed researchers in identifying such markers for assessing the severity and predicting 
the prognosis of sepsis. 
Several inflammatory biomarkers have been evaluated in recent years with the 
high sensitivity, specificity, positive and negative predictive values for the early 
diagnosis of sepsis as available in literature. The Red Cell Distribution width (RDW) is 
one of the various biomarkers which have been shown to predict the mortality and 
morbidity of sepsis. 
The Red Cell Distribution Width (RDW) is the coefficient of variation of Red 
Blood Cell (RBC) volume and is a representation of the RBC size heterogeneity of an 
individual patient.
8
 Recent studies have reported that Red Cell Distribution Width (RDW) 
is associated with prognosis in Critical Illness, Heart Failure, Acute Myocardial 
Infarction, Pulmonary Embolism, Pneumonia and Cardiac Arrest.
9-14
 
Research has shown that Neutrophil-lymphocyte count ratio (NLCR) may be 
considered a novel marker of subclinical inflammation.
15 
It represents a combination of 
two markers; neutrophils, which represent the active nonspecific mediator initiating the 
first line of defence and lymphocytes, representing the regulatory or protective 
component of inflammation. Neutrophil-lymphocyte ratio (NLR) is calculated by 
dividing the number of neutrophil count by number of lymphocyte count, usually from 
peripheral blood sample. 
 
4 
 
In this work, the haemogram parameters RDW and NLCR which are part of a 
complete blood count, easy to evaluate and which do not incur additional costs to routine 
analysis are studied; (i) to assess the efficiency of these parameters as prognostic markers 
in sepsis and in predicting the clinical outcome after 28 days as assessed by SOFA score 
in patients with sepsis, severe sepsis and septic shock and (ii) to investigate whether 
changes in RDW and NLCR during the first week correlates with the severity of sepsis 
and related complications.  
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REVIEW OF LITERATURE 
 
PREAMBLE  
Sepsis, a syndrome of physiologic, pathologic, and biochemical abnormalities induced 
by infection, is a major public health concern. Multiple definitions and terminologies are 
currently in use for sepsis, severe sepsis, septic shock, and organ dysfunction. With 
Considerable advances made into the pathobiology, the definition for sepsis and septic shock 
is being revised periodically. A 1991 consensus conference developed initial definitions for 
sepsis wherein sepsis refers to the presence of an infectious systemic inflammatory response 
syndrome (SIRS).
 16 
 
SystemicInfiammatory Response syndrom (SIRS) in adults requires two or more of the 
following.   ( Table 1) 
 
Table 1. SystemicInfiammatory Response syndrom (SIRS)  
 
1. Temperature >38 C or< 36 C 
2. Pulse>90/min 
3. RR>20/min or PaCO2<32 mm Hg 
4. WBC count >12000/cmm or <4000/cmm or >10% immature band forms 
 
                                                        
The definition was not adequate, lacked specificity and deceptive. Even patients with 
uncomplicated infections, patients in acute medical and surgical wards may satisfy SIRS 
6 
 
criteria. SIRS may simply reflect an appropriate host response that is frequently adaptive. 
Sepsis involves organ dysfunction, indicating a pathobiology more complex than infection in 
addition to an accompanying inflammatory response alone 
The definition was updated in 2001 and the international consensus defined severe 
sepsis as sepsis that leads to dysfunction of any or more organ systems, the organ dysfunction 
variables listed as,
 17
 
 
Arterial hypoxaemia (PaO2/Fi O2 ratio <300) with new pulmonary infiltrates 
A new or increased Oxygen requirement to maintain SpO2 more than 90% 
Acute oliguria (Urine output < 0.5 mL/kg/hour for at least 2 hours 
           Serum creatinine more than 176.8 µ mol/L (2.0 mg/dL) 
      Coagulation abnormality (INR >1.5 or aPT more than 60 secs 
      Thrombocytopoenia (platelet <100x 10
 9
/L ( 100000/ µL)) 
      Hyperbilurubinaemia ( total bilurubin >68.2 µmol/L(4mg/dL)) 
     Arterial hypotension ( systolic BP <90 mmHg, mean BP <65mmHg) or reduction    
      in systolic BP > 40 mm Hg from baseline) 
      Serum lactate >2 mmol/L(>18mg/dL) 
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The international consensus defines Septic shock as to satisfying the following criteria: 
 Arterial hypotension ( systolic BP <90 mmHg, mean BP <65mmHg, or 
reduction in systolic BP > 40 mm Hg from baseline) persisting for at least one 
hour despite adequate fluid resuscitation  (or) 
 Serum lactate >4 mmol/L(>36mg/dL) after adequate fluid resuscitation . 
 (The use of vasopressor agents to correct hypotension does not exclude shock). 
   As per the Surviving Sepsis Campaign (SSC) guidelines updated in 2012, severe sepsis 
is defined as sepsis plus sepsis induced organ dysfunction or tissue hypoperfusion. 
Septic shock is defined as sepsis induced hypotension persisting despite adequate fluid 
resuscitation. 
The definition was reanalyzed and modified in 2016 and it recommended that sepsis 
should be defined as life-threatening organ dysfunction caused by a dysregulated host response 
to infection. Septic shock should be defined as a subset of sepsis in which particularly 
profound circulatory, cellular, and metabolic abnormalities are associated with a greater risk of 
mortality than with sepsis alone.
7,18
  Patients with septic shock can be clinically identified with 
a presentation of  
 Persistent hypotension requiring vasopressors to maintain Mean Arterial pressure 
MAP≥65mmHg  and 
 Serum lactate >2 mmol/L(>18mg/dL) in the absence of hypovolemia  
The definition used to describe the condition of septic shock is given in Table 2.
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Table 2.  Definition used to describe the condition of septic shock 
Bacteremia Presence of bacteria in blood, as evidenced by positive 
blood cultures 
Signs of possibly harmful systemic 
response 
Two or more of the following conditions: 
(1) fever (oral temperature >38°C [>100.4°F]) or 
hypothermia (<36°C [<96.8°F]);  
(2) tachypnea (>24 breaths/min); 
 (3) tachycardia (heart rate >90 beats/min);  
(4) leukocytosis (>12,000/μL), leukopenia 
(<4000/μL), or >10% bands 
Sepsis (or severe sepsis) The harmful host response to infection; systemic 
response to proven or suspected infection plus some 
degree of organ hypofunction, i.e.: 
1. Cardiovascular: Arterial systolic blood pressure ≤90 
mmHg or mean arterial pressure  ≤70 mmHg that 
responds to administration of IV fluid 
2. Renal: Urine output <0.5 mL/kg per hour for 1 h 
despite adequate fluid resuscitation 
3. Respiratory: PaO2/FiO2 ≤250 or, if the lung is the only 
dysfunctional organ,≤200 
4. Hematologic: Platelet count <80,000/μL or 50% 
decrease in platelet count from highest value recorded 
over previous 3 days 
5. Unexplained metabolic acidosis: A pH ≤7.30 or a base 
deficit ≥5.0 mEq/L and a  plasma lactate level >1.5 times 
upper limit of normal for reporting lab 
Septic shock Sepsis with hypotension (arterial blood pressure <90 
mmHg systolic,or 40 mmHg less than patient’s normal 
blood pressure) for at least 1 h despite adequate fluid 
resuscitation
a
 
or 
Need for vasopressors to maintain systolic blood pressure 
≥90 mmHg or mean arterial pressure ≥70 mmHg 
Refractory septic shock Septic shock that lasts for >1 h and does not respond to 
fluid or pressor administration 
 
a 
Fluid resuscitation is considered adequate when the pulmonary artery wedge pressure is ≥12 mmHg or the central venous 
pressure is ≥8 mmHg. 
Source: Harrison, Principles of Internal Medicine, Vol 2; 19
th
 edition,Mc Graw Hill Education 
Publishers p 1751 
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Fig 1. Sepsis - Disease continuum 
              
 
                          
 
 
                                               Fig 2. Effects of sepsis 
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EPIDEMIOLOGY 
Recent estimates indicate that the incidence of sepsis has increased in the past 3 
decades.
19
 About 1.5 million people in the United States are diagnosed with sepsis every year. 
The incidence of severe sepsis and septic shock in the United States has increased to 750000 
every year (about 3/1000 population).
20 
It is reported that, one out of every 4 people admitted 
with severe sepsis die during hospital stay. There is a similar trend of increase in the incidence 
of sepsis worldwide. The reason for this increased incidence may be attributed to increase in 
the lifespan of general population, leading to increase number of ageing population, and the 
association of chronic diseases like diabetes, cardiac diseases, chronic obstructive pulmonary 
disease and malignancy. The frequent use of in-dwelling catheter and immunosuppressants has 
also contributed to the rise in the number of patients with sepsis and severe sepsis globally 
every year. Sepsis has been more commonly associated with African and Afro- American 
males and also HIV infected individuals. In spite of improvement in health care and treatment 
modalities, the mortality of patients with severe sepsis and septic shock continues to be high. 
AETIOLOGY: 
In 2007, a prevalence study was conducted in over 14000 patients in Intensive Care 
units across more than 70 countries to identify the etiological pattern of sepsis. In the study,  
51 % of the patients were considered to be infected, of which respiratory tract infection was 
found to be most common. In another study conducted by Mayr et.al., respiratory tract 
infection was found to be the most common cause in adults , followed by bloodstream 
infection of unspecified etiology, followed  in order by genitourinary, abdominal, soft tissue 
11 
 
and catheter related infections.
21
  Microbial invasion of bloodstream is not essential in all cases 
of sepsis, as local inflammation can lead to distant organ dysfunction. Studies have shown that 
only 20 to 40 percentage of cases of severe sepsis and 40 to 70 percentage cases of septic 
shock yield positive blood culture for bacteria or fungus. 
More frequent use of broad-spectrum antibiotics in critically ill patients who remain in 
the ICU for longer periods of time has resulted in a high degree of bacterial resistance over 
time.
22,23 
Antibiotic resistance is challenging, resulting in longer duration of hospital stay and 
ventilator dependence, although the effect on mortality is uncertain.
24-26
 Among causative 
agents, Gram Negative organisms were found to be the most common cause of sepsis (62%), 
but, of late, incidence of Gram positive organisms as a cause of sepsis is on the rise and are 
now becoming almost as common as Gram negative organisms  (46%).
 19, 27-29
.This trend may 
be due to the greater use of invasive procedures and increasing magnitude of hospital acquired 
infections
26
. Recent European prevalence of infection in Intensive Care (EPIC-2) study 
reported that the incidence of Gram negative organisms to be around 62 % compared to Gram 
positive organisms at 42%.The study also showed that among individual organisms, 
Staphylococcus aureus was found to be the most common pathogen (20.5%) followed by 
 Pseudomonas (19.9 %) and Enterobacteriae,  particularly E.Coli. A large meta-analysis of 
more than 500 studies demonstrated that Gram negative bacteraemia leads to more mortality 
than Gram positive bacteraemia
30
.
 
Coagulase negative staphylococci and E coli were the 
commonest cause of bloodstream infections. Pseudomonas aeruginosa had the highest 
mortality rate among all (77%). Gram positive pneumonia caused by Staphylococcus aureus 
12 
 
was the next common cause (41%). Candida and Acenobacter species also accounted to high 
mortality rates (40%). 
Recent studies have shown that there has been an increased incidence of sepsis among 
paediatric population over the past decade. This has been largely due to the disproportionate 
increase in the incidence of sepsis among neonates, particularly among the low birth weight 
category
31
. Again, respiratory tract infections were found to be the most common cause of 
sepsis even among paediatric population (49%) followed by primary bacteremia (18.1%). 
RISK FACTORS 
Risk factors for severe sepsis can broadly be divided into risk factors for infection, 
contingent upon developing infection, and risk factors for organ dysfunction. 
Bacteraemia 
     Patients with bacteraemia often developed systemic consequences of infection. In a 
study conducted in 2015 in South Korea in patients with sepsis, whose blood cultures were 
positive for either bacteria or fungi, about 95% of positive blood cultures were associated with 
sepsis severe sepsis or septic shock. 
Sex and race 
Sepsis has been found to be more common among male gender and black people 
(African and Afro- American). 
 Environmental factors 
There exists an inverse relationship between socioeconomic status and the risk for 
development of sepsis.
32
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Age 
Elderly patients, particularly above 65 years, are at increased risk of developing sepsis. 
The incidence of sepsis increases with age, and older adults above 65 years of age have an 
increased risk of mortality from sepsis compared to their younger counterparts. Age is also 
an independent prognostic marker in sepsis. Elderly individuals need greater nursing care and 
close monitoring. Studies have shown that in-hospital mortality rates are higher among elderly 
individuals affected with sepsis. 
Immunosuppression 
Immunosuppression is an important risk factor for the development of sepsis. 
Conditions that affect the host defence mechanisms and those drugs that lead to 
immunosuppression make the patient more vulnerable for developing frequent infections and 
their poor immunity make them candidates for the development of sepsis. Some of these 
conditions include renal failure, diabetes, neoplasms, hepatic failure, AIDS, patients on 
corticosteroid therapy or immunosuppressant medications. The risk of progression to severe 
sepsis, septic shock and Multi Organ Dysfunction Syndrome (MODS) is more common among 
immunosuppressed individuals which may lead to high mortality. 
Malignancy and diabetes 
Diabetes and malignancies alter the immune system resulting in an increase in the risk 
for developing sepsis.  Studies have shown that there is high incidence of nosocomial 
infections among patients with diabetes, particularly among patients with poor glycemic 
control. 
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Community acquired pneumonia 
Patients who developed community-acquired pneumonia were found to have an 
increased risk of developing sepsis and an increased risk of progression to severe sepsis and 
septic shock. 
Genetic factors 
There is confirmatory evidence from experimental and clinical studies that genetic 
factors can increase the risk of infection in few cases. Monogenic defects underlie 
vulnerability to specific infection, but genetic factors are typically genetic polymorphisms. 
Genetic studies of susceptibility to infection have initially focused on defects of antibody 
production or a lack of T- cells, phagocytes, natural killer cells or complement, but recently 
genetic defects that impair the recognition of pathogens by the innate immune system have 
been recognised. Study by Sorensen et al., suggests that genetic factors may play a crucial role 
in outcomes of infectious diseases compared with cardiovascular disease. In this study, 
children whose biological parents died due to infectious causes had an 8 fold increased risk of 
death due to infections
33
. In comparison, the increased risk of death due to cardiovascular 
causes was four fold if their biological parents died of cardiovascular causes. 
PATHOPHYSIOLOGY 
The normal host responds to any infection in a peculiar fashion aiming towards 
localising and restricting the bacterial invasion. The host responds by triggering the activation 
of circulating macrophages resulting in the production of pro-inflammatory and anti- 
inflammatory cytokines. When microbial organisms enter the host, it responds by triggering 
15 
 
the innate immune cells, particularly macrophages, to identify and bind to the microbial 
components. This process may occur as follows. 
 When the microorganisms enter the host, the host immune cells have certain 
pattern recognition receptors on their cell surface that identify and attach to the Pathogen 
Associated Molecular Patterns (PAMP) 
1
of the microorganism. There are three major groups 
of  Pattern Recognition Receptors: 
         1) Toll -like receptors (TLR) 
         2) Nucleotideoligomerization domain (NOD) leucine Rich repeat proteins and 
         3) Retinoic acid inducible gene I (RIG--i) like helicases. 
The host immune cells also contain triggering receptors expressed on myeloid cell (TREM-1) 
and Myeloid DAP -12 associating  Lectin (MDL-1) on their surface which identify and bind to 
the microorganisms
2
.The binding of Toll like receptors triggers a signalling cascade by 
activating the cytosolic nuclear factor -kb (NF-kb). The activated NF-kb  migrate from the 
cytoplasm to the nucleus, attaches itself to the transcription sites, and trigger the activation of a 
large set of genes resulting in the release of pro-inflammatory cytokines like Tumor necrosis 
factor-Alpha,Interleukin-1, chemokines  like Intercellular Adhesion Molecule-1(ICAM -1) and 
Vascular Cell Adhesion Molecule-1(VCAM-1)  and nitric oxide. 
The polymorphonuclear leukocytes also get activated and express adhesion molecules 
on their surface that leads to their aggregation and margination to the vascular endothelium. 
The polymorphonuclear leukocytes then undergo a series of steps such as rolling, adhesion, 
diapedesis, and chemotaxis to move to the site of injury.
34
 The poly morphonuclear leukocytes 
now release inflammatory mediators at the site of injury which leads to the cardinal signs of 
16 
 
local inflammation. This process is regulated by the release of pro-inflammatory and anti -
inflammatory mediators by the macrophages at the site of injury that is triggered by the 
invasion of tissue by the microorganisms.
35-37
 
The balance in the pro-inflammatory and anti- inflammatory mediators control and 
regulate the inflammatory process, which leads to homeostasis, overcoming of the infectious 
insult and ultimately results  in tissue repair and healing
38
. When this inflammatory response to 
infection exceeds the boundary of local environment and becomes a more generalized 
response, it leads to widespread tissue damage and is called sepsis. In the absence of any 
infectious etiology, this process is called Systemic Inflammatory Response Syndrome (SIRS). 
The reason why the localised immune response sometimes crosses the local environment 
leading to sepsis is still not clear. 
 It may be due to the direct effect of microorganisms or their toxic products. 
Bacterial cell wall components like endotoxin, peptidoglycan, muramyl dipeptide and 
lipotechoic acid and bacterial products like Staphylococcal enterotoxin-B, toxic shock 
syndrome toxin-1, pseudomonas exotoxin A, and M-protein of hemolytic group A  
streptococci may contribute to the progression of a local infection to sepsis.
39-41
 
 Large quantities of pro-inflammatory cytokines released during sepsis may 
spill into the bloodstream leading to the progression of local infection to sepsis. These include 
tumor necrosis factor-alpha and interleukin-1 whose plasma levels peak early and eventually 
decrease to undetectable levels. There is strong evidence that TNF - α has an important role to 
play in sepsis.
42, 43
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 The complement system is a protein cascade which helps in clearing 
pathogens.
44, 45
 There is proven evidence in animal studies that activation of complement 
system plays a vital role in sepsis. 
46, 47
 
Genetic susceptibility 
Single nucleotide polymorphism (SNP) is the commonest type of genetic variation. 
Various SNPs are associated with high degree of susceptibility to infection. Some of these 
include SNPs  of genes  that encode cytokines  like TNF-α, IL-10, IL-18,IL-1 receptor 
antagonist, IL-6  and Interferon gamma; cell surface receptors like  CD14, MD2 , toll-like 
receptors 2 and 4; lipopolysaccharide ligands like lipopolysaccharide binding protein, 
bactericidal permeability increasing protein, mannose-binding lectin, heat shock protein 70, 
angiotensin I-converting enzyme, and caspase-12. 
48
 
SYSTEMIC EFFECTS OF SEPSIS 
When the immune response to bacterial invasion becomes generalised, it leads to 
widespread cellular injury. Organ dysfunction eventually follows this cellular injury. The 
precise mechanism of cellular injury is not understood, but various mechanisms have been 
proposed explaining the process of cellular injury. These include tissue ischemia, cytopathic 
injury and an altered rate of apoptosis. 
A) TISSUE ISCHEMIA 
During sepsis there occurs a significant derangement in metabolic auto- regulation 
which is the process that matches oxygen availability to changing tissue oxygen demand. 
Moreover, during sepsis, microcirculatory and endothelial lesion frequently develops. These 
18 
 
lesions decrease the cross sectional area available for tissue oxygen exchange reading to tissue 
ischemia and cellular injury
49
.  
B) CYTOPATHIC INJURY 
The pro- inflammatory mediators released during sepsis may lead to mitochondrial 
dysfunction through a variety of mechanisms, like direct inhibition of respiratory enzyme 
complexes, oxidative stress damage and mitochondrial DNA breakdown.
50
 Such mitochondrial 
injury leads to cytotoxicity. . 
C) APOPTOSIS 
      Apoptosis is the primary mechanism by which senescent or dysfunctional cells normally 
get eliminated. It is the principal process by which inflammation gets terminated once an 
infection has subsided. The pro-inflammatory cytokines that are released during sepsis delay 
the process of apoptosis in the activated macrophages and neutrophils, disrupting the normal 
inflammatory response mechanism and leading to the development of multiple organ failure. 
In addition to this, there is also an extensive apoptosis of lymphocytes and dendritic cells 
which alters the immune response that occurs during sepsis. The extent of lymphocytic 
apoptosis correlates with the severity of sepsis and the level of immunosuppression. 
 Apoptosis has also been found to occur in epithelial cells, endothelial cells and parenchymal 
cells. Several animal studies have shown that inhibiting the process of apoptosis has been 
protective from organ dysfunction.
51,52
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Fig  3a.  Pathophysiology of sepsis - Flow chart 
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                                 Fig  3b. Pathophysiology of sepsis and septic shock 
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ORGAN SPECIFIC EFFECTS OF SEPSIS 
The cellular injury accompanied by the release of pro-inflammatory and anti -
inflammatory mediators leads to the development of organ failure. Multi organ dysfunction is 
not uncommon. 
Circulation: 
Circulatory dysfunction leads to diffuse vasodilatation resulting in hypotension. 
Inflammatory mediators like nitric oxide and prostacyclin are released by the endothelial cells 
in sepsis to induce appropriate vasodilatation for the purpose of improving metabolic auto -
regulation. But diffuse vasodilation occurs as unintended consequences of these inflammatory 
mediators, which results in hypotension. Nitric oxide, particularly is believed to play an 
important role in the process of vasodilatation during septic shock.
53,54
 When nitric oxide 
reaches the systemic circulation, it depresses the auto regulation at all the- central, regional 
and micro regional levels of circulation .Vasodilatation is not the only cause of hypotension in 
sepsis. It may also be due to the redistribution of intravascular fluid which occurs as a 
consequence of increased endothelial permeability and reduced arterial vascular tone. In 
addition to these diffuse effects on circulation, there are also localised effects. 
 During sepsis myocardial depressant substances that are released into the 
circulation impair the systolic and diastolic ventricular performance of the heart. The 
myocardium may still be able to use the Frank- Starling law and maintain the cardiac output in 
normal individuals. But patients with pre-existing cardiac disease are often unable to increase 
their cardiac output appropriately, further contributing to hypotension. 
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 Sepsis is associated with a reduction in the number of functional capillaries 
 as a result of which there is subnormal oxygen extraction through the micro circulation. 
 Sepsis induces phenotypic changes to endothelial cells. This occurs through 
 direct and indirect interactions between the endothelial cells and components of the bacterial 
wall. These phenotypic changes lead to endothelial dysfunction, which is associated with 
coagulation abnormalities, reduced leukocytes, decreased red blood cell deformability, 
upregulation of adhesion molecules, adherence of platelets and leukocytes and degradation of 
the glycocalyx structure.
55 
Diffuse endothelial activation results in widespread tissue edema. 
 Micro particles from circulating and vascular cells also participate in the  
deleterious effects of sepsis-induced intravascular inflammation 
56
. 
Lung 
Endothelial injury that occurs in the pulmonary vasculature during sepsis impairs 
capillary blood flow and leads to increased micro vascular permeability.This leads to 
interstitial and alveolar edema. The neutrophil entrapment in the pulmonary vasculature 
further amplifies the injury, the end result being pulmonary edema and hypoxemia. This type 
of pulmonary edema that occurs in sepsis is called as acute respiratory distress syndrome. 
Gastrointestinal tract 
The circulatory abnormalities that occur in sepsis disrupt the GIT‘s normal barrier 
function, leading to translocation of bacteria and endotoxin from the gut into the systemic 
circulation, thus further amplifying the septic process. 
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Liver  
  Liver dysfunction can contribute to the initiation and progression of sepsis. Normally, 
the reticuloendothelial system of the liver is the first line of defence in clearing bacteria and 
bacteria-derived products that enter the portal system from the gut. Liver dysfunction can 
prevent the elimination of enteric-derived endotoxin and bacteria-derived products, which 
results in direct spillover of these harmful products into the systemic circulation. 
57, 58
 
Kidney  
Sepsis is often associated with acute kidney injury. The renal hypoperfusion that occurs 
in sepsis leads to organ dysfunction. Systemic hypotension, direct renal vasoconstriction, 
release of cytokines such as Tumor Necrosis Factor, may also contribute to renal injury.  
Nervous system  
 Central nervous system complications occur very commonly in septic patients. 
Encephalopathy and peripheral neuropathy are the commonest complications. 
 Encephalopathy: The pathogenesis of the encephalopathy is poorly defined. 
A high incidence of brain microabscesses was noted in one study, but the significance of 
hematogenous infection as the principal mechanism remains uncertain. 
 Peripheral neuropathy: Studies suggest that at least 25 percent of patients 
 admitted to medical or surgical intensive care units have some degree of acquired paresis
59,60
. 
Affected patients manifest a sensorimotor polyneuropathy characterized by limb muscle 
weakness and atrophy, reduced or absent deep tendon reflexes, sensory loss to light touch and 
pin prick, and relative preservation of cranial nerve function
61
.The mechanism of axonal injury 
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in this condition is unknown. CNS dysfunction may be attributed to changes in metabolism 
and alterations in cell signalling due to the release of inflammatory mediators. 
CLINICAL MANIFESTATIONS AND COMPLICATIONS 
The clinical manifestation of patients with sepsis includes signs and symptoms that are 
common to any septic response and those manifestations that occur as a complication of the 
septic response. Moreover, some of the clinical manifestations can give a clue to the primary 
etiology contributing to the sepsis. Most patients are hyperthermic, whereas some patients 
maybe normothermic or hypothermic. Hypothermia is commonly seen in elderly, neonates and 
alcoholics. Hyperventilation producing respiratory alkalosis is a very common early 
manifestation in sepsis. Disorientation, confusion and other manifestations of encephalopathy 
can develop early. Blood glucose levels increase in septic patients, particularly in diabetics. 
Protein catabolism is accelerated. Serum albumin levels decrease due to impaired hepatic 
synthesis and due to the movement of albumin into the interstitial spaces. 
COMPLICATIONS 
Cardio pulmonary complications 
Alveolar epithelial injury and increased alveolar capillary permeability leads to 
increased pulmonary water content. This interferes with gas exchange and produces arterial 
hypoxemia. Ultimately acute lung injury and acute respiratory distress syndrome will result. 
.Hypotension occurs as a result of hypovolemia and generalised redistribution of blood flow in 
sepsis. Dehydration may further contribute to hypotension. Also, as a part of the septic 
response, the myocardial function becomes depressed within the first 24 hours in most patients 
with sepsis. In patients with no pre existing cardiac failure, the cardiac output is usually 
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maintained in spite of the myocardial depression. The myocardial function restores to normal 
over several days. So the primary cause of hypotension is usually a decreased systemic 
vascular resistance. 
Renal complications 
Oliguria, azotaemia, proteinuria are the commonest renal complications. Most renal 
failure occurs due to acute tubular necrosis as a result of hypovolemia and hypotension. 
Coagulopathy 
Thrombocytopenia is common in patients with sepsis. In patients with DIC, the platelet 
counts are very low, usually less than 50000. The exact mechanism for thrombocytopenia is 
unclear. 
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Neurological complications 
 
Confusion, altered sensorium (acute encephalopathy) occurs as early manifestation of 
sepsis. Studies show that encephalopathy occurs in around 20 to 60 percentage of septic 
patients at some point during the course of illness. 
Immunosuppression 
Patients with severe sepsis often become immune suppressed. This leads to increased 
risk for secondary infection and difficulty in controlling the primary infection.  
LABORATORY INVESTIGATIONS AND DIAGNOSIS 
The most common laboratory findings that are seen in sepsis include neutrophilic 
leukocytosis, thrombocytopenia and hyperbilirubinemia. Urine analysis may show mild-to-
moderate proteinuria. Leukopenia may be seen in some individuals. Peripheral smear may 
reveal neutrophilia with neutrophils containing toxic granules. In severe sepsis, 
thrombocytopenia usually worsens and may be associated with prolonged thrombin time, 
decreased fibrinogen levels and elevated D -dimer levels suggesting DIC. Serum creatinine 
and blood urea nitrogen levels are commonly elevated in patients with severe sepsis and septic 
shock, indicating renal hypoperfusion and acute kidney injury. Arterial blood gas analysis 
usually reveals high anionic gap metabolic acidosis though in many patients early arterial 
blood gas analysis may show respiratory alkalosis as a result of hyperventilation. The most 
common ECG abnormality seen is sinus tachycardia. Chest X-ray may reveal underlying 
pneumonia or features of acute respiratory distress syndrome (ARDS). Bacteraemia is very 
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common and blood cultures may reveal the causative organism. In case of suspected urinary 
tract infection, urine cultures are helpful. In patients with in-dwelling catheter or soft tissue 
infections, swabs taken from the catheter or wound should be sent for culture. 
DIAGNOSTIC AND PROGNOSTIC MARKERS 
  There is no specific diagnostic test for sepsis. Several diagnostic and prognostic 
markers are being studied by researchers in patients with sepsis. Some of these biomarkers 
which are proved to be helpful in the diagnosis and predicting the severity and outcome to 
some extent are discussed below. 
C - reactive protein: 
CRP levels are being used extensively as a non-specific marker of inflammation. 
Several studies have demonstrated the increase in CRP levels in patients with sepsis
62, 63
.
 
As 
CRP levels are also increased in many other inflammatory conditions like rheumatoid arthritis, 
crohns disease, myocardial infarction, CRP is a nonspecific marker of sepsis. Because baseline 
CRP levels are often raised in these comorbid chronic inflammatory conditions, changes in 
concentrations over time and serial monitoring of CRP levels in patients with sepsis are more 
useful than single values
64, 65
.  
Procalcitonin 
Many studies have shown that procalcitonin levels are elevated in patients with sepsis
66
.  
Several studies have validated Procalcitonin to be a more reliable marker of sepsis than CRP, 
and that, it can be used to distinguish between sepsis caused by bacteria and other  
organisms
67, 68
.There is also evidence based data that higher procalcitonin levels are associated 
with increased mortality thus making it a good prognostic marker as well
69
. 
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Cytokine Levels 
Various inflammatory cytokines, that are key mediators of the sepsis response, have 
been studied for their role as biomarkers of sepsis, some of which include IL-6, TNFα and 
 IL-8. The serum levels of these inflammatory cytokines have been shown to be increased in 
patients with sepsis.
70
  
Soluble Triggering Receptor Expressed on Myeloid Cells-1 
Serum levels of sTREM-1 are found to be elevated in patients with sepsis.
 71-74 
Several 
studies have suggested that they are more sensitive and specific for infection than other 
markers such as CRP and procalcitonin.
71,72
 A decrease in sTREM-1 levels over time was 
associated with a good prognosis in patients with sepsis.
75
 
CD 64 
Neutrophilic  CD 64 expression  have been studied in patients with sepsis and were 
found to have  moderate sensitivity and specificity  in the diagnosis of sepsis.
76,77
 
Clot Waveform Analysis 
Toh et al have established in their studies on patients diagnosed with sepsis and severe 
sepsis, the optical transmission waveform obtained during measurement of the activated partial 
thromboplastin time showed a biphasic pattern. The presence of this abnormal waveform has 
been used to support a diagnosis of sepsis
78
. 
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PREDICTION OF OUTCOME OF SEPSIS:    SCORING SYSTEMS 
      Severity of organ dysfunction has been assessed with various scoring systems that quantify 
abnormalities according to clinical findings, laboratory data, or therapeutic interventions. 
 APACHE II (Acute Physiology and Critical Health Evaluation score) 
The APACHE II score is one of the many scoring systems available such as SOFA, 
SAPS III, RIFLE  to assess the prognosis of individual patients based on the set of  laboratory 
values  and the patient’s sign of illness both acute and chronic illness. For APACHE II 
scoring, the input data should be that of the initial 24 hours of the patient’s entry into the ICU. 
The scores are assigned according to the criteria given in table (Table 3) 
SOFA SCORE 
In 1994, The European Society of Critical Care Medicine (ESCCM), developed a 
simple and objective score, the Sequential Organ Failure Assessment (SOFA) Score as a 
system for measuring the status of the patient in the ICU.
79,80
 The organ dysfunction in sepsis 
is recommended to be identified by an acute change in total SOFA score ≥ 2 points consequent 
to infection. The Sequential Organ Failure Assessment (SOFA) score allows for calculation of 
both the number and the severity of organ dysfunction in six organ systems, ie, respiratory, 
coagulatory, liver, cardiovascular, renal, and neurologic .The score can measure individual or 
aggregate organ dysfunction. Different variables and parameters are included in each of the 
organ system (Table 4). The function of each is scored from 0 (the Normal function-unless the 
patient has a previously known co-morbidity like cirrhosis, chronic kidney disease etc) to 4 
(the most abnormal condition), giving a possible score of 0 to 24 on each day of ICU stay. The 
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sum of the highest score per individual during the entire ICU stay is considered the Maximal 
SOFA score. A higher SOFA score is associated with an increased probability of mortality
81
. 
The value of  SOFA score> 15 is supposed to predict a mortality of 90%. Mean SOFA score is 
the average of all total SOFA scores in the entire period of ICU stay. Studies reveal that mean 
SOFA score for the first 10 days is significantly higher in non-survivors. Aditi Jain et al   
made prospective study on  patients of age between 15 and 80 years admitted to ICU over 8 
weeks period and concluded that  there is a high correlation of  ΔSOFA score (significance 
p<0. 0001) and the mortality
82
. The maximum score in survivors (3.92 ±2.17) was 
significantly lower than that of non-survivors (8.9 ± 3.45), while duration of the stay did not 
correlate with the survival (p = 0.461).  
qSOFA score 
  SOFA score computation is a tedious procedure and uses a treatment related variable 
(doses of vasopressor agents). Laboratory variables, namely, PaO2, platelet count, creatinine 
level and bilirubin level are needed for full computation. The qSOFA score (Table 5) focuses 
on only three clinical variables- hypotension (Systolic blood pressure ≤ 100mm Hg ), altered 
mental status and tachypnea ( respiratory rate > 22/min), the presence of at least two of these 
criteria strongly predicts the likelihood of poor outcome in patients with clinical suspicion of 
sepsis in the non-ICU environment.  
This definition, nevertheless, does not offer clear criteria for sepsis diagnosis. In this 
context, sepsis raises multiple problems of diagnosis and prognosis, and further studies are 
necessary to identify useful criteria for establishing a rapid and correct diagnosis and quick 
and effective treatment.  
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Table  3  APACHE II Scoring system 
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Table 4 SOFA Score 
Organ system                                                              SOFA score 
0 1 2 3 4 
Respiration 
PaO2/FiO2 
mm Hg 
≥400 < 400 < 300 <200 with 
respiratory support 
<100 with 
respiratory support 
Coagulation 
platelets 
x10
3
/µL 
≥ 150 
 
>150 >100 >50 >20 
Hepatic 
Bilurubin mg/dL 
<1.2 1.2-1.9 2.0-5.9 6.0-11.9 >12.0 
CNS 
Glascow Coma 
Scale 
15 13-14 10-12 6-9 <6 
Cardiovascular MAP ≥70mm 
Hg 
MAP <70mm Hg Dopamine<5 
or 
dobutamine 
(any dose)
 *
 
Dopamine 5.1-15  or 
epinephrine≤0.1  or 
norpinephrine≤0.1* 
Dopamine >15 or 
epinephrine>0.1 or 
norpinephrine>0.1
*
 
Renal Serum 
Creatinine 
mg/dL 
<1.2 1.2-1.9 2.0-3.4 3.5-4.9 >5.0 or dialysis 
Or urine output    Or < 500mL/24 h Or < 200mL/24 h 
*Catecholamine doses are given as µg/kg/min for at least 1 hour 
PaO2 - Partial pressure of Oxygen; FiO2 –Fraction of inspired Oxygen 
PaO2/FiO2 ratio is calculated without reference to the use or mode of mechanical ventilation and without 
reference to the use or level of PEEP. 
Glascow Coma Score- For the patient receiving sedation or muscle relaxants, normal function is assumed unless 
there is evidence of intrinsically altered mentation. 
  
 
 
Table 5 qSOFA score 
 
2 or more of 
1. Hypotension: SBP less than or equal to 100mm Hg 
2. Altered mental status ( any CGS < 15 
3. Tachypnoea: Respiratory rate ≥ 22 
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OTHER BIOMARKERS  
Extensive studies have been done on identifying specific markers for rapid diagnosis in 
order to improve the clinical management of sepsis. The literature focuses on RDW and NLCR 
i.e., the haemogram parameters which are easy to evaluate, and which do not incur additional 
costs to routine analysis. Normally red cell size variation is known as anisocytosis. The red  
blood cell distribution width (RDW) represents an index of the heterogeneity of the 
erythrocytes (anisocytosis) which is calculated by dividing the standard deviation of 
erythrocyte volume by the mean corpuscular volume (MCV) and multiplying by 100 to 
express the result as a percentage. 
Structure of the Red cell 
Among the cells of human tissues mature RBCs are unique, in the sense that they 
normally lack nuclei and cytoplasmic structures such as Lysosomes, endoplasmic reticulum 
and mitochondria. Hence they cannot carry out protein synthesis, and are unable to undergo 
mitosis and mitochondrial oxidative reactions. RBCs are biconcave discs of 7-8µm in 
diameter, but their shape changes to a parachute- like configuration in the capillaries whose 
diameter, is less than that of RBCs in the biconcave disc form. As the membrane of red cell is 
elastic they resume biconcave shape. Once they re-enter the large blood vessels, loss of 
flexibility or elasticity leads to membrane damage and change in shape .This leads to 
diminished life span. 
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RED CELL DISTRIBUTION WIDTH (RDW) 
Red cell distribution width is an index of variation in RBC size or RBC volume. Most 
automated instruments produce a quantitative assessment of the variation in red cell volume 
indicated by RDW which corresponds to the microscopic analysis of the degree of 
anisocytosis. The RDW derived from pulse height analysis can be expressed either as (SD) 
standard deviation in fl or as the percent of coefficient of variation (CV) of the measurements 
of red cell volume. 
RDW-SD is a measurement of width of RBC size distribution histogram and it is 
measured by calculating the width at the 20% height level of the RBC size distribution 
histogram. Hence RDW-SD is not influenced by the average RBC size, that is, mean 
corpuscular volume. 
RDW-CV is calculated from standard deviation and MCV by the formula.  
RDW-CV (%) = 1 SD of RBC volume / MCV x 100% 
Since RDW- CV is obtained mathematically from MCV it is affected by changes in average 
size of RBCs. 
Normal reference ranges of RDW in adults: 
                                             RDW - SD                 39-46 fl  
                                             RDW - CV                 12-14%  
Significance of elevated RDW 
 Early diagnosis of nutritional deficiency (d/t) iron, B12 and folic acid. 
 Differentiation of iron deficiency anaemia from thalassemia. 
 Differentiation of megaloblastic anaemia from other causes of macrocytosis. 
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 Identification of Red cell fragmentation, agglutination and dimorphic red cells in 
peripheral smear examination. 
Red cell distribution width in sepsis 
Recent studies have been focusing on evaluating RDW’s prognostic value and use for 
the diagnostic role in sepsis. Literature reveals that as RDW is a means of evaluating the 
variability in size of erythrocytes it has been used widely in the differential diagnosis of 
anemia 
83
.Since RDW is a marker of unspecific inflammation, it can show high value in many 
other diseases such as heart failure, stroke, peripheral arterial disease or chronic pulmonary 
diseases 
84
.Red cell distribution width (RDW) represents an indicator which can vary in sepsis, 
under the influence of pro-inflammatory cytokines (TNFα, IFNδ, IL-1β, IL-6)85,released 
during the inflammatory process. These cytokines cause inefficient erythropoiesis resulting in 
structural and functional changes of erythrocytes, with volume variations and increased RDW. 
Elevated value of RDW can also appear in nutritional deficiencies such as iron deficiency 
anaemia, vitamin B12 or folate deficiency anaemia, or in blood transfusions
86
.  
Kim et al. evaluated the predictive role of RDW regarding the short and medium-term 
mortality in elderly patients with severe sepsis and septic shock and concluded that every one 
percent (1%) increase in RDW is equivalent to a 15% increase in the mortality rate in the first 
30 days 
87
. Lorente et al. showed that RDW is a low-cost procedure which should be routinely 
performed to identify the risk of death in sepsis. In this study, the prognostic value of RDW 
was compared with other biomarkers such as serum malondialdehyde and TNFα, 88  
In a study on 349 patients, the function of RDW in predicting septic outcome in sepsis 
through the statistically significant association with APACHE II score and with hospital 
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mortality rate. (p<0.0001) was presented. This study demonstrated that an RDW value over 
16% is concurrent with a higher APACHE value and risk of death
84
. RDW was also 
considered a good predictor of the length of hospitalisation for septic patients admitted to 
intensive care units 
89
.  
The biomarker RDW proved its usefulness as an outcome measure because an 
ascending trend of RDW in the first 72 hours of admission is associated with an unfavourable 
prognosis, even though the initial values were normal
90
. Chen et al. analysed almost 7000 adult 
patients with sepsis, with a mortality rate of 6.8%. In this study, patients who died had higher 
initial values of RDW than the survivors (15.7% versus 13.8%). There were also established 
threshold values; for RDW over than 15.6%, the risk of death was 16.7%, for RDW between 
14 – 15.6% it was 7.3%, and for RDW under 13.1% the mortality rate was 1.6%. Thus, RDW 
was considered to be a superior mortality predictive factor to SIRS criteria, the MEDS (Mor-
tality in Emergency Department Sepsis) or CURB65 scores 
91
.  
SIGNIFICANCE OF NLCR 
Neutrophil/lymphocytes count ratio (NLCR) has been the focus of several recent 
studies as it is accessible, cheap and readily determined. The importance of this parameter is 
related to the pathophysiological mechanism of SIRS, which is characterised by an increased 
number of circulating leucocytes, due to the increased number of neutrophils, the first line of 
antimicrobial defence. On the other hand, lymphocytopenia appears as a consequence of 
lymphocyte margination and redistribution in the lymphatic system, with accelerated  
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apoptosis 
92
. Normally there are 4000-11000 WBCS/ micro litre in the human blood. Of these 
granulocytes are the most numerous. Young granulocytes have horse shoe shaped nuclei that 
become multilobed as the cells grow older. Most of them contain neutrophilic granules. 
Neutrophils 
Neutrophils have cytoplasmic granules that contain biologically active substances 
involved in inflammatory reactions. The average half- life of a neutrophil in the circulation is 6 
hours. They are attracted to the endothelial surface by selectins and they roll along it. 
Neutrophil adhesion molecules of the integrin family helps them to get bound to selectins. 
They insinuate themselves through the walls of the capillaries by a process known as 
diapedesis. Many of those that leave the circulation enter the GI tract and are lost from the 
body.Neutrophilic granules contain various proteases and in addition they also contain 
enzymes such as NADPH oxidase, catalase and myeloperoxidases. NADPH oxidase is 
associated with a sharp increase in oxygen intake and metabolism in the neutrophil, 
(Respiratory burst) and this reaction generates plenty of free O-radicals. The myeloperoxidase 
catalyses the conversion of Halides and cyanides to their corresponding acid forms. These 
acids in turn are potent oxidants by themselves.In addition to myeloperoxidase and NADPH 
oxidase neutrophil granules also contain an elastase and two metalloproteinases. 
The total body neutrophils can be divided into circulating pool (CGP) and marginating 
granulocyte pool. In these two pools, the cells are equal size and they are in constant 
equilibrium. MGP represents the neutrophils involved in adhesion and rolling along the 
endothelial cells in post capillary venules and they are not found in blood obtained by 
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venepuncture. So the neutrophil content actually represents about half of the total no of 
neutrophils in the vascular compartment. 
Lymphocytes 
Lymphocytes are motile non phagocytic cells. There are many subpopulations of 
lymphocytes which interact with each other and with cells of the monocyte macrophage 
system. They help in maintaining both humoral and cell mediated immunity. Proliferating 
lymphocytes are enriched with enhanced levels of enzyme n-terminal deoxyribonucleic acid 
transferase. It is found in immature lymphoid cells in the bone marrow and thymocytes, but 
not in mature lymphocytes. Adenosine de aminase is present in large amounts in T-
lymphocytes and it is necessary for their immune function. 
Inflammation 
Inflammation is naturally a protective mechanism against invasion of microbes and 
toxins. The inflammatory response consists of 2 main components- a vascular reaction and a 
cellular reaction. Both the reactions are mediated by chemical factors that are derived from 
plasma proteins or cells produced as a result of inflammatory response. 
Mechanisms 
Endothelial dysfunction secondary to cellular response of blood components heralds the 
onset of inflammation. Endothelial dysfunction leads to impaired production of nitric oxide 
and prostacylins. This leads to the depletion of anti-atherogenic, antithrombotic and 
vasodilator properties of the vascular endothelium. 
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Zahorec first proposed the use of the ratio of neutrophil and lymphocyte counts 
[neutrophil lymphocyte count ratio (NLCR)] as an marker of infection in clinical  
Applications. 
93
 Loonen et al., demonstrated that NLCR is a rapidly available biomarker, and 
appears most promising in differentiating patients with BSI from those without BSI for 
subsequent pathogen identification.
94 
NLCR is considered to be superior to other biomarkers 
such as CRP, leukocytes count or neutrophils count, as a predictor for bacteraemia in patients 
admitted to emergency or intensive care units.
95
  In a study of 40 patients with severe sepsis, 
Okashah et al., highlighted NLCR superiority regarding sensitivity, specificity, positive and 
negative predictive values to other parameters like lactate, CRP, neutrophils count, 
lymphocytes count, or leucocytes count.
96
 The same study showed the usefulness of NLCR in 
prognostic evaluation attributing to the statistically significant correlation with two severity 
scores, APACHE II (p=0.01) and SOFA (p=0.01).  
Recently, attempts have been made to establish threshold values for NLCR for 
predicting the severity and outcome of the disease. A more recent study showed that an initial 
value of NLCR over 10 could be correlated with an unfavourable prognosis, as assessed by the 
number of SIRS criteria, the presence of organ failures or septic metastasis at admission. 
Despite the low number of investigated patients, this study intended to substantiate the 
prognostic role of NLCR in sepsis through the statistically significant correlations with 
APACHE IV (p=0.01) and APS (p=0.01) scores and with the estimated rate of mortality 
(p=0.01)
97
. A retrospective study, which included 2311 patients with bacteraemia concluded 
that a value of NLCR over seven on admission, represented an independent increased 
mortality rate risk factor 
98
. 
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The predictive role of NLCR has been evaluated not only in septic patients but also in 
patients with tumours, cardiovascular diseases or intestinal inflammatory diseases. The initial 
value of this indicator was correlated with the outcome and with the survival rate in patients 
with different types of cancers: pulmonary, breast, prostatic, pancreatic, oesophageal 
99
, 
colorectal 
100
 or hepatocellular carcinoma followed by liver transplant 
101
.Several studies, 
published in cardiovascular medicine domain, showed the prognostic role of NLCR in patients 
with an acute coronary syndrome, aortocoronary bypass or congestive heart failure 
102,103
. Ertas 
et al. indicated that NLCR was useful in the prognosis of patients with thromboembolic  
Stroke.
104
 On the other hand, a high correlation between NLCR and the outcome of patients 
with gangrenous appendicitis was demonstrated, and was shown to be superior to other 
parameters like fever, CRP, Leucocytes number or the Glasgow scale.
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MANAGEMENT OF SEPSIS 
Early Management 
For patients with severe sepsis or septic shock, (i) stabilization of the airway and 
breathing and (ii) restoration of perfusion to the peripheral tissues should be should be done 
immediately, by supplemental oxygenation and monitored continuously with pulse oximetry.  
Intubation and mechanical ventilation if needed should not be delayed.
106, 107
 
Following initial stabilization, chest radiographs and arterial blood analysis should be 
obtained in combination with other clinical parameters to diagnose acute lung injury (ALI) or 
acute respiratory distress syndrome (ARDS), which frequently complicate sepsis.  
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Central venous Catheter (CVC)   
After the assessment of airway and perfusion, inserting a central venous catheter will be 
beneficial with most patients with severe sepsis and septic shock for infusion of intravenous 
fluids, infusion of blood product and infuse medications. In addition, CVC can be used to 
monitor the central venous pressure (CVP) and the central venous oxyhaemoglobin saturation 
(ScvO2).  Few studies have shown that, managementt of septic shock guided by ScvO2 reduce 
the mortality. 
108
 
 Restoration of Perfusion 
Once the presence of hypoperfusion has been established, early restoration of perfusion 
is vital to prevent or reduce multi organ dysfunction. The goals for resuscitation of circulation 
include maintaining central venous pressure (CVP) 8 to 12 mmHg, a mean arterial pressure 
(MAP) ≥65 mmHg and a urine output ≥0.5 mL/kg per hour.Intravenous fluid administration 
should be started as early as possible. 
Intravenous fluids  
Large volume infusions of IV fluids are the main stay of initial therapy in patients with 
severe sepsis or septic shock. Fluid should be administered as rapidly infused boluses 
109,110
. 
The volume status, blood pressure, peripheral perfusion and the presence of lung signs (to rule 
out pulmonary edema) must be monitored before and after each bolus. Intravenous fluids 
should be administered carefully and a more restrictive approach should be followed with 
respect to fluid resuscitation in patients at risk and who have developed acute lung injury or 
ARDS.
111
 The ideal fluid of choice can be either a colloid like 0.9 % normal saline or Ringer’s 
Lactate or crystalloids like 4%  albumin or pentastarch. Though 0.9 % normal saline is the 
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most commonly used and preferred fluid of choice for many clinicians, the usefulness of 
crystalloids have been studied extensively. 
In a SAFE (Saline versus Albumin Fluid Evaluation) trial, nearly 7000 critically ill 
patients were studied after being randomly assigned to receive 4% albumin to one group and 
normal saline to another group. It was observed that, after 28 days, there was no difference in 
the outcome between the two groups. In another trial called VISEP trial, a similar comparison 
was done between two groups. One group received penta- starch (colloid) and another group 
received Ringer’s lactate (crystalloid). The trial was stopped due to an increased trend in 90 
day mortality among patients who received pentastarch
112
.Generally, crystalloids like normal 
saline/ Ringer’s lactate are preferred due to the higher cost of colloid. 
Vasopressors and Inotropes 
In the treatment of severe sepsis and septic shock, though vasopressors are second line 
agents, intravenous vasopressors are the next step in patients who remain hypotensive despite 
adequate fluid resuscitation or who develop cardiogenic pulmonary edema
113
. 
The choice of vasopressor agents have been studied .Use of norepinephrine  in most 
patients were recommended and phenylephrine  (a pure alpha-adrenergic agonist) was 
observed to be useful when tachycardia or arrhythmias preclude the use of agents with beta-
adrenergic activity
106,114
 When the ScvO2 remains <70 percent after optimization of 
intravenous fluid and vasopressor therapy, additional therapies such as inotropic therapy or red 
blood cell transfusion could be considered. 
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IDENTIFYING AND REMOVING THE SEPTIC FOCUS 
The primary therapeutic intervention involves the identification and treatment of the 
primary site or sites of infection, the other interventions being purely supportive
115-117
. A 
careful history and physical examination may yield clues to the source of sepsis and help guide 
microbiologic evaluation. For example, the presence of a urinary or intravenous catheter 
increases the chances that these are the source of infection. The catheters should be removed 
immediately and changed if warranted. Gram staining and culture of samples from the 
suspected source of infection should be collected as early as possible and sent to reliable 
laboratory without contamination. Source control measures should be undertaken since 
undrained foci of infection may not respond to antibiotics alone. For examples, abscesses 
should be drained as early as possible. 
ERADICATION OF INFECTION  
Antimicrobial regimen   
Intravenous antibiotic therapy should be started immediately after obtaining  culture 
samples, since early initiation of antibiotic therapy is associated with lower mortality 
118
.The 
choice of antibiotics depends on the patient's history with suspected source of infection and 
targetting suspicios pathogens, recent antibiotics received 
119
, comorbidities, clinical context 
(eg, community- or hospital-acquired), Gram stain data, and local resistance patterns 
106,120-122
. 
Generally clinicians prefer starting broad-spectrum antibiotics when the potential pathogen or 
infection source is not immediately obvious. The initial antimicrobial therapy pertaining to the 
 clinical condition is listed in Table 6. 
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Table  6. Initial Antimicrobial therapy for severe sepsis with no obvious source in adults with 
Normal renal function  
 
Cl Clinical condition lllM Antimicrobial regimens(Intravenous therapy) 
Immunocompetent adult The many acceptable regimens include  
(1) piperacillin-tazobactam (3.375 g q4–6h); 
 (2) imipenem-cilastatin (0.5 g q6h), ertapenem (1 g q24h),or 
meropenem (1 g q8h); or 
(3) cefepime (2 g q12h). If the patient is allergic to β-lactam 
agents, use ciprofloxacin (400 mg q12h) or 
levofloxacin (500–750 mg q12h) plus clindamycin (600 mg 
q8h).Vancomycin (15 mg/kg q12h) should be added to each of 
the above regimens. 
Neutropenia 
 (<500 neutrophils/μL) 
Regimens include (1) imipenemcilastatin (0.5 g q6h) or 
meropenem (1 g q8h) or cefepime (2 g q8h) or 
(2) piperacillin-tazobactam (3.375 g q4h) plus 
 tobramycin (5–7 mg/kg q24h). Vancomycin (15 mg/kg q12h) 
should be added if the patient has an indwelling vascular 
catheter, has received quinolone prophylaxis, or has received 
intensive chemotherapy that produces mucosal damage; if 
staphylococci are suspected; if the institution has a high 
incidence of MRSA infections; or if there is a high 
prevalence of MRSA isolates in the community. Empirical 
antifungal therapy with an echinocandin  
(for caspofungin: a 70-mg loading dose,then 50 mg daily), 
voriconazole (6 mg/kg q12h for 2 doses, then 3 mg/kg q12h), or 
a lipid formulation of amphotericin B should be added if the 
patient is hypotensive, has been receiving broad-spectrum 
antibacterial drugs, or remains febrile 5 days after initiation of 
empirical antibacterial therapy. 
Splenectomy Cefotaxime (2 g q6–8h) or ceftriaxone (2 g q12h) should be 
used. If the local prevalence of cephalosporinresistant 
pneumococci is high, add vancomycin. If the patient is allergic 
to β-lactam drugs, vancomycin (15 mg/kg q12h) plus either 
moxifloxacin (400 mg q24h) or levofloxacin (750 mg q24h) 
should be used. 
IV drug user Vancomycin (15 mg/kg q12h) is essential. 
AIDS Cefepime alone (2 g q8h) or piperacillintazobactam 
(3.375 g q4h) plus tobramycin (5–7 mg/kg q24h) should be used. 
If the patient is allergic to β-lactam drugs, ciprofloxacin 
(400 mg q12h) or levofloxacin (750 mg q12h) plus vancomycin 
(15 mg/kg q12h) plus tobramycin should be used 
Abbreviation: MRSA, methicillin-resistant Staphylococcus aureus. 
Source: Adapted in part from DN Gilbert et al: The Sanford Guide to Antimicrobial Therapy, 
43rd ed, 2013 
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        Fig 4. Sepsis Management  
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SURVIVING SEPSIS CAMPAIGN BUNDLES 
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Literature reveals that extensive work has been done in the diagnostic and early 
treatment of sepsis in developed countries. Research is still going on in the identification of 
markers to diagnose sepsis, severe sepsis and septic shock from SIRS. More of research is 
needed to identify biomarkers in this area in developing countries. Hence this study is 
undertaken to find the effectiveness of the biomarkers Red cell distribution width (RDW) and 
Neutrophil-Lymphocyte count ratio (NLCR) as prognostic markers of sepsis and to correlate it 
with SOFA score in predicting the outcome.  
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AIM AND OBJECTIVE 
 
  
The aim of the study is to investigate whether changes in RDW and NLCR during 
the first week correlates with the severity of sepsis and to assess the efficiency of  RDW 
and NLCR in predicting the clinical outcome after 28 days as assessed by SOFA score in 
patients with sepsis, severe sepsis and septic shock. 
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MATERIALS AND METHODS 
 
The study was performed at the Government Stanley Medical College Hospital 
Chennai from April 2017- September 2017, after obtaining the approval of the Internal 
Ethical Committee of Government Stanley Medical College & Hospital, Chennai. 
Informed written consent from all the patients considered for the study was procured 
before conducting the study. 
STUDY DESIGN AND PATIENT SELECTION 
It is a prospective observational study. 85 adult patients of both sex with a 
diagnosis of sepsis and admitted in the emergency wards and Intensive medical Care unit 
in the Stanley Medical college hospital under the Department of Medicine were included 
in the study.  
INCLUSION CRITERIA 
 Patients admitted to the emergency ward and intensive medical care unit who meet 
the criteria of sepsis, severe sepsis and septic shock. 
 Patients of Age > 18 years 
EXCLUSION CRITERIA 
 Patients of Age < 18 years  
 Patients diagnosed with anaemia or with haematological disorders 
 Patients with diseases causing trauma, intoxication 
 Patients with  immuno-suppressive disease, receiving immuno-suppressive therapy 
or using drugs that can change the morphology of red blood cells 
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 Patients with bleeding > 10% volume 
 Patients who had received recent transfusion of blood products 
 Patients with malignancies and on chemotherapy(within the last 6 months) 
 Pregnant individuals. 
METHODOLOGY 
Patients were assessed for sepsis, severe sepsis, and septic shock Society of 
Critical Care Medicine Conference definitions
18
. Blood samples were collected and 
analysed within 3 hrs from the time of presentation. Clinical, and laboratory data were 
obtained and blood culture was studied before administration of broad spectrum 
antibiotics. Red blood cell distribution width (RDW), circulating Neutrophil to 
lymphocyte counts ratio (NLCR) were obtained from the values measured at the time of 
presentation. The value considered to be normal for leukocyte was5.2-12.4 x10
3μL for 
neutrophil and 0.9-5.2 x10
3μL for lymphocyte.  
The principles of initial resuscitation (fluid therapy, vasopressors, inotropic 
support) and infection issues (source identification and control, appropriate antibiotic 
therapy ) were followed regularly and the outcome studied. SOFA score was recorded at 
admission in the emergency ward or ICU for studying the in- hospital outcome.RDW, 
Neutrophil count, Lymphocyte count and calculation of NLCR were done at the time of 
admission, after 72 hours and after 7 days of treatment. Major adverse cardiovascular 
events in the form of cardiogenic shock requiring inotropic support, pulmonary edema 
and death were recorded. The correlation studies of RDW, NLCR, and SOFA score is 
done.  
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The following were the investigations done for the patients entering into the study. 
 Complete Blood Count 
 Renal function test 
 Peripheral smear 
 Serum electrolytes 
 Liver function test 
 ECG  
 Chest  X Ray , 
 USG Abdomen, 
 CT/MRI  
 Lumbar Puncture 
 Arterial Blood Gas analysis 
 Blood culture 
 Urine culture 
 Pus culture 
 Sputum culture 
 Sputum for acid-fast bacilli 
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SAMPLE COLLECTION  
Blood Samples 
A random sample was collected from the anticubital vein of the study subjects. The blood 
samples were analysed on the same day within 3 hours of collection. The biochemical 
parameters relevant to the study were analysed by the following methodologies.  
Estimation of RDW, RBC Count and NLCR 
CBC WITH DIFFERENTIAL TEST METHOD 
Sysmex XN and XS Systems: 
 WBC:  Flow cytometry 
 RBC:  Impedance counting 
 Platelet Count: Impedance counting 
 Platelet F Count: Flow cytometry fluorescence count (performed when 
appropriate) 
 HGB:  Converted to SLS-hemoglobin and read photometrically. 
 MCV:  The average volume of individual erythrocytes derived from the RBC 
histogram. 
 RDW:  The size distribution spread of the erythrocytes population derived from 
the RBC histogram 
 MPV:  The average volume of individual platelets derived from the PLT 
histogram. 
 HCT: Measured as a ratio of the total RBC volume to whole blood using 
cumulative pulse height detection. 
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 MCH, MCHC:  Calculated parameters. MCH: Weight of HGB in the 
average RBC.  
MCHC: Average weight of HGB in a measured dilution. 
MCHC = HGB ÷ HCT x 100 
 WBC Differential: The instrument makes 3 measurements (volume, 
conductivity and scatter) as each cell passes through the flow cell. The low 
frequency impedance measurement defines cell volume. The high frequency 
conductivity measurement indicates the internal conductivity. The light scatter 
measurement indicates the structure and shape. An algorithm is applied to 
determine different cell populations. 
 Abs Neutrophils, Abs Lymphocytes, Abs Monocytes, Abs Eosinophils, Abs 
Basophils: Calculated Parameters [Total WBC x (%Diff Analyte Result/100)] = 
Absolute Diff Analyte Count 
 NLCR =
𝑇𝑜𝑡𝑎𝑙  𝑛𝑒𝑢𝑡𝑟𝑜𝑝 ℎ𝑖𝑙  𝑐𝑜𝑢𝑛𝑡
𝑇𝑜𝑡𝑎𝑙  𝑙𝑦𝑚𝑝 ℎ𝑜𝑐𝑦𝑡𝑒  𝑐𝑜𝑢𝑛𝑡
 
Reference Values 
RBC count Male  4.5 to 5.9 m/cumm 
RBC count Female  3.8 to 5.2 m/cumm 
Haemoglobin Male  13 to 18 g/dl 
Haemoglobin Female  11.5 to 16.5g/dl 
PCV Male  42 to 50% 
PCV Female  36 to 45% 
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MCV 80 to 100 fl 
MCH 27 to 31 pg 
MCHC 32 to 36 g/dl 
RDW-CV 11.6 to 14 % 
Total WBC Count 4000 to 11000 cells/ cumm 
Differential Count 
Neutrophils 40 to 75% 
Lymphocyte 20 to 45% 
Eosinophils 1 to 6% 
Monocyte 2 to 10% 
Basophils 0 to 1% 
Platelets Count 1.5 to 4.5 Lakhs / cumm 
ESTIMATION OF UREA 
Technique 
Urea (UV- GLDH) SLR – Assay 
Principle 
The test is performed as a 2 point kinetic assay in which the initial rate of the 
reaction is linear for a limited period of time. Urea in the sample is hydrolyzed by urease 
to ammonia and carbondioxide. The second reaction, catalyzed by the glutamate 
dehydrogenase converts ammonia and alpha-ketoglutarate to glutamate and water. Two 
moles of NADH are oxidized for each mole of urea present. 
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The initial rate of decrease in absorbance at 340 nm is proportional to the urea 
concentration in the sample. 
Sample Collection 
Serum is collected by standard procedure. Heparin is recommended as anticoagulation. 
Calculation 
A Sample  
A Standard  
x (50 Standard Concentration) 
= mg/dl urea in the sample. 
Reference Range 15-39mg/dl 
ESTIMATION OF CREATININE 
Technique 
Liquixx Creatinine (Modified Jaffe’s Method) 
Principle 
Creatinine reacts with alkaline picrate to produce orange- yellow colour (The 
Jaffe’s Reaction). Specificity of assay has been improved by the introduction of an initial 
rate method.The absorbance of the orange-yellow colour formed is directly proportional 
to creatinine concentration and is measured photometrically at 500-520nm. 
Sample 
Serum 
Calculation 
 A of  Test
 A of  Standard
x Concentration of Standard (mg/dl) 
= Creatinine mg/dl 
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Reference Range 
Males 0.7 to 1.4mg/dl;                   Females 0.6 to 1.2mg/dl 
STATISTICAL ANALYSIS 
Data was entered in Micro soft Excel format. Frequency tables and measures of 
central tendency (mean) and measures of dispersion (standard deviation) were calculated 
using the statistical package SPSS 2.0 version. For the repeated measures the Friedman 
test was used. To find the significance in categorical data Chi-Square test was used. In all 
the above statistical tools, the probability value .05 is considered as significant level. 
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RESULTS AND ANALYSIS 
 
The study subjects were patients admitted in the Government Stanley Hospital, 
Chennai, presenting with the syndrome of sepsis and who were selected according to the 
inclusion criteria. The sample size was determined according to the formula 
The formula for determining sample size is given as: 
 
 
 
 
 
 where, 
 
n = Sample size,   σ = Population standard deviation 
 
E = Margin of error  and  Zα/2 is normal deviate for two-tailed alternative hypothesis at a 
level of significance; for example, for 5% level of significance, Zα/2 is 1.96 and for 1% 
level of significance it is 2.58.The confidence level is estimated at 95% 
Standard deviation 2.2 
With a z value of 1.96 the confidence interval or margin of error is  
estimated at ± 0.05.Assuming that 80 percent is considered as power of the study, the 
minimum sample size required for the study is calculated to be 75 
           Taking into account 10% attribution rate = 75+8=83 
           Thus 85 subjects of both sex, male and female had been chosen in our study.  
Out of the 85 subjects studied, 69 were survivors. This accounts to 81.18% of the sample 
population. The Non-survivors were 16 (18.82%) including 5 patients who died on the 
day of presenting the illness. 
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The mean age was 52.61 years in survivors group and 64 years in non-survivors 
group (Table 4.1 & Table 4.2).When compared statistically using unpaired t test, the 
difference in mean age between study groups was found to be significant (p<0.05). Age 
was progressively associated with mean age difference of 11.39 years increase shown in 
non-survivors group compared to survivors group (18% increase). Further, Cohen’s effect 
size value (d = .86) suggested a high practical significance (80% study subjects with age 
above 64 years suffering from sepsis in non-survivor group will have death as outcome) . 
It shows that increase in age in sepsis patient is associated with increase in mortality. 
Table 4.1 Age group of the subjects 
Age groups Survivors % Non-survivors % 
≤ 20 years 1 1.45 1 6.25 
21-40 years 14 20.29 0 0.00 
41-60 years 36 52.17 2 12.50 
61-80 years 18 26.09 12 75.00 
> 80 years 0 0.00 1 6.25 
Total 69 100.00 16 100.00 
Table 4.2 Age Distribution 
Age Distribution Survivors Non-survivors 
Mean 52.61 64.00 
SD 12.09 14.55 
P valueUnpaired t Test 0.0016 
The male-female survival ratio was 59.42:40.58. Among the non-survivors, 
females showed a high rate of mortality (62.5%) (Table4.3). When compared statistically 
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using chi squared test, the difference in gender percentage differences between study 
groups was found to be insignificant (p>0.05). 
Table 4.3 Gender Status 
Gender Status Survivors % Non-survivors % 
Male 41 59.42 6 37.50 
Female 28 40.58 10 62.50 
Total 69 100.00 16 100.00 
P value 
Chi Squared Test 
0.1121 
 
Among the survivors 56.5% were without any comorbidity, 5.8% with COPD; 
14.5% in nonsurvivors and 4.4% in survivors presented with stroke (Fig 4.5a &Fig 4.5b). 
Diabetes Mellitus and hypertension were the most common comorbid conditions in both 
the groups followed by chronic kidney diseases. But in the non-survivors group, Diabetes 
Mellitus (37.5 %.)  and hypertension with Diabetes Mellitus ( 31.25%) showed a high 
percentage and only 6.25% had no comorbidity. One subject diagnosed for sepsis had 
comorbidity of Tuberculosis and hypertension (6.25%). It may be concluded that the 
occurrence of comorbidities like Diabetes Mellitus and hyper tension and chronic kidney 
diseases pose a higher risk of death outcome. 
Among the survivors group, respiratory tract infection, urinary tract, blood stream, 
soft tissue and  abdominal infection were found to be the common source of infection, 
(26.09%,21.74%,15.94%, 15.94% and 14.49% ). Respiratory/urinary tract infection was 
observed in  non-survivors group (n=5, 31.25%).  (Table 4.4, Fig 4.6) 
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Table 4.4 Source of infection 
Source of Infection Survivors % Non-survivors % 
Abdominal 10 14.49 2 12.50 
Blood Stream 11 15.94 0 0.00 
CNS 2 2.90 1 6.25 
Respiratory 18 26.09 5 31.25 
Soft tissue 11 15.94 3 18.75 
Urinary Tract 15 21.74 5 31.25 
Iatrogenic 2 2.90 0 0.00 
Total 69 100.00 16 100.00 
P value-Chi Squared Test 0.6563 
 
Chi squared test analysis showed that the difference with respect to source of infection 
between study groups was found to be insignificant (p>0.05) leading to the conclusion 
that the source of infection in patients with sepsis is not associated with increase in death 
outcome, rather, the comorbidity and age also  play a role in the outcome. 
Table4.5 shows that the causative agents in majority of the study subjects were 
gram –ve agents in survivors group (n=30, 43.48%) and gram +ve/gram –ve agent in 
non-survivors group (n=4, 25%).   
Table 4.5 Causative Agents 
Causative Agent Survivors % Non-Survivors % 
Not Isolated 21 30.43 7 43.75 
Gram +ve 16 23.19 4 25.00 
Gram -ve 30 43.48 4 25.00 
Anaerobic 1 1.45 1 6.25 
Fungus 1 1.45 0 0.00 
Total 69 100.00 16 100.00 
P value 
Chi Squared Test 
0.3068 
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When compared statistically using chi squared test, based on the causative agent, 
percentage differences between study groups was found to be insignificant (p>0.05). 
It was observed that the severity of sepsis is associated with mortality (Table4.6) 
Majority of the study subjects in survivors group had mild sepsis (n=44, 63.77%) and in 
Non-survivors group majority had septic shock (n=13, 81.25%). The chi squared test 
analysis (p>0.05) and Cohen's effect size value (d=0.71) suggested a moderate practical 
significance showing that septic shock is associated with the significant increase in death 
outcome. 
Table 4.6 Severity of sepsis in the subjects 
Stage of Sepsis Survivors % Non-survivors % 
Sepsis 44 63.77 1 6.25 
Severe Sepsis 9 13.04 2 12.50 
Septic Shock 16 23.19 13 81.25 
Total 69 100.00 16 100.00 
P value 
Chi Squared Test 
<0.0001 
 
In our study, the mean SBP was 96.23mm Hg in the survivors group and 53.75 
mm Hg in the non-survivors group. When compared statistically using unpaired t- test, 
the difference in mean between study groups was found to be significant (p<0.05). SBP 
was inversely associated with decreasing mean difference of 42.48 mm Hg in non-
survivors group compared to survivors group (44% decrease). Cohen’s effect size value 
(d = 2.45) suggested a high practical significance (96% study subjects with SBP below 54 
mm Hg suffering from sepsis will have death as outcome. The mean Diastolic blood 
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pressure was 60.29 mm Hg in the survivor group and 36.25mm Hg in the non-survivors 
group. Using the unpaired t- test, the difference in mean between study groups was found 
to be significant (p<0.05). DBP was inversely associated with decreasing mean difference 
of 24.04 mm Hg in non-survivors group compared to survivors group (40% decrease). 
Further, Cohen’s effect size value (d = 2.65) suggested a high practical significance 
(100% study subjects with DBP below 36 mm Hg suffering from sepsis will have death 
as outcome). 
Table 4.7 Systolic Blood Pressure among groups 
Systolic Blood 
Pressure groups 
Survivors % Non-survivors % 
≤ 40 mm Hg 0 0.00 7 43.75 
41-60 mm Hg 0 0.00 5 31.25 
61-80 mm Hg 22 31.88 4 25.00 
81-100 mm Hg 28 40.58 0 0.00 
> 100 mm Hg 19 27.54 0 0.00 
Total 69 100.00 16 100.00 
 
Table 4.8Systolic Blood Pressure Distribution 
Systolic Blood Pressure 
Distribution 
Survivors Non-survivors 
Mean 96.23 53.75 
SD 21.29 13.10 
P value 
Unpaired t -Test 
<0.0001 
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Table 4.9 Diastolic Blood Pressure among groups 
Diastolic Blood 
Pressure groups 
Survivors % Non-survivors % 
≤ 30 mm Hg 1 1.45 6 37.50 
31-50 mm Hg 17 24.64 10 62.50 
51-70 mm Hg 44 63.77 0 0.00 
71-90mm Hg 7 10.14 0 0.00 
Total 69 100.00 16 100.00 
 
Table 4.10 Diastolic Blood Pressure Distribution 
Diastolic Blood Pressure 
Distribution 
Survivors Non-survivors 
Mean 60.29 36.25 
SD 13.17 5.00 
P value 
Unpaired t -Test 
<0.0001 
 
SOFA score analysis showed that the SOFA score was ≤ 5 for 73.91% of the 
survivors, the mean SOFA score being 3.36 (Table 4.11, Table 4.12). The SOFA score 
for non-survivors was found to be high (between 11 and 15) and the mean was 11.06. The 
unpaired t test (p<0.05) and Cohen’s effect size value (d = 3.59) showed high 
significance of  SOFA score in predicting the outcome of patients during the in-hospital 
stay, higher the SOFA score, higher would be the mortality rate.(Table4.11) 
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Table 4.11 SOFA Score 
SOFA Score 
Groups 
Survivors % Non-survivors % 
≤ 5 51 73.91 0 0.00 
6 to 10 16 23.19 4 25.00 
11 to 15 2 2.90 12 75.00 
> 15 0 0.00 0 0.00 
Total 69 100.00 16 100.00 
 
Table 4.12 SOFA Score Distribution 
SOFA Score Distribution Survivors Non-survivors 
Mean 3.36 11.06 
SD 2.67 1.61 
P value 
Unpaired t -Test 
<0.0001 
 
Mean duration of in-hospital stay was 10.48 in the group of survivors and majority 
of them belonged to 6-10 days class interval. In the non-survivors group, all were treated 
in the ICU including 5 patients who died on the day of presenting the illness 
(Table4.13&4.14). Inotropic support was given to all the 16 non-survivors (100%). 
Among the survivors group, only a few (20.29%) needed inotropic support (Table4.15). 
When compared statistically using chi squared test, a percentage difference of 79.71% 
was found to be insignificant (p>0.05).Further, Cohen’s effect size value (d = .80) 
suggested a moderate practical significance (79%) of the study subjects leading to a 
conclusion that increase in the need for inotropic support in sepsis patients is associated 
with a significant increase in death outcome. 
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Table 4.13 Place of treatment ICU/Ward 
Place of 
Treatment 
Survivors % Non-survivors % 
Ward 46 66.67 0 0.00 
ICU 23 33.33 16 100.00 
Total 69 100.00 16 100.00 
P value 
Chi Squared Test 
<0.0001 
 
Table 4.14 Duration of stay as in-patient  
Duration of 
Stay Status 
Survivors Non-survivors 
No. % Mean &SD No. % Mean &SD 
≤ 5 days 0 0.00 
Mean=10.48 
 
SD=3.59 
13 81.25 
Mean=3.50 
 
SD=0.71 
6-10 days 46 66.67 3 18.75 
11-15 days 17 24.64 0 0.00 
16-20 days 4 5.80 0 0.00 
> 20 days 2 2.90 0 0.00 
Total 69 100.00 16 100.00 
 
Table 4.15 Inotropic support 
Inotropic 
Support 
Survivors % Non-survivors % 
Yes 14 20.29 16 100.00 
No 55 79.71 0 0.00 
Total 69 100.00 16 100.00 
P value 
Chi Squared Test 
<0.0001 
 
 
 
66 
 
 
Majority of the subjects in both the survivors and the non-survivors were 
presenting with multiple complications, like Acute Kidney Injuries(20.29%; 56.25%), 
thrombocytopenia (30.43%;6.25%), coagulopathy (8.7%;31.25%), metabolic acidosis 
(18.84%;62.5%), encephalopathy (8.7%;87.5%), jaundice (5.8%;18.75%)  and ARDS 
(1.45%; 31.25%) (Fig4.14a, Fig 4.14b).This was associated mostly with patients with a 
history of diabetes and hypertension. Presence of complications was associated with 
increased incidence of death outcome in non-survivors group compared to survivors 
group (48% increase). Further, Cohen’s effect size value (d = 1) suggested a moderate 
practical significance (84% study subjects suffering from sepsis presenting with 
complications will have death as outcome). 
RDW and NLCR values were studied on Day 1(within 3 hours), after 72 hours and 
after 7 days.(Table4.16, Table 4.17). 
Table4.16 Analysis of variation of RDW from Day 1 to Day 7 
RDW At Admission After 72 Hours After 7 Days 
Survivors 
Mean 16.22 15.94 15.79 
SD 0.89 0.84 0.76 
Non-
survivors 
Mean 19.08 18.93 18.87 
SD 1.04 0.63 0.76 
P value Unpaired t-Test <0.0001 <0.0001 <0.0001 
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Table4.17Analysis of variation of NLCR from Day 1 to Day 7 
NLCR At Admission After 72 Hours After 7 Days 
Survivors 
Mean 8.95 7.41 5.34 
SD 1.54 1.78 1.61 
Non-survivors 
Mean 13.24 11.95 10.67 
SD 1.37 1.36 0.58 
P value Unpaired t-Test <0.0001 <0.0001 <0.0001 
 
From the RDW Vs Sepsis table (Table 4.18), it was evident that the study subjects 
with sepsis had a mean RDW of 15.92, with severe sepsis had a mean RDW of 16.73 and 
with septic shock had a mean RDW of 18.06.  When compared statistically using single 
factor ANOVA test, the difference in mean RDW between various stages of sepsis was 
found to be significant (p<0.05). RDW in sepsis patients was progressively associated 
with increased sepsis status exhibiting a increasing mean difference of 0.80 between 
sepsis stage and severe sepsis stage (5% increase) followed by a increasing mean 
difference of 1.33 between severe sepsis stage and septic shock stage (7% increase). 
Also, Cohen’s effect size value (d = 1.88) suggested a high practical significance (97% 
study subjects with RDW at admission above 18.06 will have septic shock as outcome). 
Table 4.18 Significance of RDW as biomarker 
RDW Vs Sepsis Sepsis Severe Sepsis Septic Shock 
Mean 15.92 16.73 18.06 
SD 0.80 0.87 1.46 
P value 
Single Factor ANOVA Test 
<0.0001 
 
68 
 
With respect to NLCR Vs Sepsis table, it was evident that the study subjects with 
sepsis had a mean NLCR of 8.30, with severe sepsis had a mean NLCR of 10.23 and with 
septic shock had a mean NLCR of 11.85 (Table 4.19).  When compared statistically using 
single factor ANOVA test, the difference in mean NLCR between various stages of 
sepsis was found to be significant (p<0.05). NLCR in sepsis patients was progressively 
associated with increased sepsis status exhibiting a increasing mean difference of 1.93 
between sepsis stage and severe sepsis stage (19% increase) followed by an increasing 
mean difference of 1.62 between severe sepsis stage and septic shock stage (14% 
increase). Further, Cohen’s effect size value (d = 2.43) suggested a high practical 
significance (99% study subjects with NLCR at admission above 11.85 will have septic 
shock as outcome). 
Table 4.19 Significance of NLCR as biomarker 
NLCR Vs Sepsis Sepsis Severe Sepsis Septic Shock 
Mean 8.30 10.23 11.85 
SD 1.03 2.40 1.88 
P value 
Single Factor ANOVA Test 
<0.0001 
 
We might conclude that the increasing trend of RDW and NLCR in patients 
treated for sepsis is associated with a significant upscaling of sepsis status from sepsis to 
septic shock. To study the effectiveness of RDW and NLCR in the prediction of 
mortality, and the outcome after 28 days, the cut off value, odds ratio and probability 
value were calculated (Table 4.20). 
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Table 4.20 Prediction of mortality 
 
Independent 
Variable 
 
Dependent 
variable 
Cut off 
Odds 
ratio 
95% Confidence Interval  
(CI) 
p value 
RDW 
 28 days 
mortality 
18 162.5 
 
2.53 to 988.34 
 
<0.0001 
NLCR 
 
14 50.04 24.91 to1059.89 0.0101 
 
  The cut off value suggested that sepsis patients with NLCR> 14 had 50 times more 
risk of death after 28 days compared to sepsis patents with NLCR ≤ 14 .Sepsis patients 
with RDW> 18 had 162 times more risk of death at 28 days compared to sepsis patents 
with RDW ≤ 18 
Correlation studies of (a) RDW with SOFA score and (b)NLCR with SOFA score 
were made. In sepsis patients, when RDW was cross matched against SOFA score, a 
positive correlation with Pearson’s correlation coefficient of r=0.81 was found. In sepsis 
patients, the increase in levels of RDW correlates with the increase in SOFA score 81% 
of times The statistical significance was found to be p value is < 0.0001.(Table 4.21) 
Table 4.21 Correlation of RDW with SOFA score 
RDW Vs SOFA Score Correlation 
Pearson’s R 0.81 
R Square 0.65 
F statistic 157.52 
P value <0.0001 
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Table 4.22 reveals that when NLCR was cross matched against SOFA score, the increase 
in levels of NLCR correlates positively and strongly with the increase in SOFA score 
85% of times. This correlation is statistically significant as the p value is < 0.0001 with a 
Pearson’s coefficient of 0.85. 
Table 4.22 Correlation of NLCR with SOFA score 
NLCR Vs SOFA Score Correlation 
Pearson’s R 0.850095 
R Square 0.722662 
F statistic 216.2736 
P value <0.0001 
 
It may be concluded from the highly significant and positive correlation of RDW 
with SOFA score and that of NLCR with SOFA score indicate that RDW and NLCR can 
be used as the prognostic markers in patients with sepsis, severe sepsis and septic shock. 
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Fig 4.13 Variation of RDW in the course of treatment 
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Fig 4.18 RDW/NLCR Vs severity of sepsis 
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Fig 4.19 NLCR Vs SOFA score 
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DISCUSSION 
Our study is a prospective observational study  aimed  at  assessing the 
usefulness  of  Red Cell Distribution Width and Neutrophil Lymphocyte Count Ratio  in 
predicting the prognosis and mortality among  patients diagnosed with sepsis. The study 
was conducted in 85 patients admitted to the Emergency ward ICCU and General 
medical wards in Stanley Medical College Hospital. Most of the subjects were in the 42-
65 years age group, of which 47 were males and 38 being females. This may point out to 
the high incidence of sepsis in elderly group’s individuals.  
Angus et al.,
20 
observed that the incidence of severe sepsis was higher in older 
population. The mean age of patients with severe sepsis was 63.8 years. In another study 
conducted by Martin et al, there was an increased incidence of sepsis by about 20 % more 
in the elderly population compared to younger individuals
19.
The reason for this high 
incidence among elderly population may be due to the fact that, in recent years life 
expectancy has increased in general and that with increasing age, individuals develop 
various comorbidities like diabetes and malignancy which increase the risk of developing 
sepsis. In our study the mortality rate in patients above 60 years of age was found to be 
the highest (75%) among all age groups. This is in correlation with many studies that 
have been conducted worldwide that have observed that there was an increased mortality 
rate among elderly patients diagnosed with sepsis. The incidence of sepsis was slightly 
higher among male patients compared to females. Studies have shown that women appear 
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to be at a lower risk of developing sepsis than men. The reason for this is unclear though 
in a study Angele et al., explored and published the possible role of estrogens and 
androgens that lead to gender differences in the incidence of sepsis.
123 
We could not come 
to a conclusion based on gender incidence  as our study group was small  and as there 
was  not much significant difference in male and female incidence. 
The most common presenting symptom was fever followed by cough and altered 
sensorium. The most common source of infection was respiratory tract followed by 
urinary tract infections. Community-acquired Pneumonia was the other most common 
cause of infection. This was partly in correlation with the study conducted by Mayr et al
21
 
respiratory tract infection accounted to the highest etiology of sepsis followed by 
bloodstream and site unspecified infections. The highest mortality was observed in 
patients with respiratory tract infections (31.25%) and urinary tract infections 
 (31.25%) . Gram Negative organisms were found to be the most common causative 
organisms (41.18%) followed by Gram Positive organism (24.71%). Diabetes and 
hypertension were the most common associated comorbidities observed. The mortality 
rate was highest among diabetes patients. The duration of hospital stay was also increased 
among diabetic patients. Interestingly, this was in contrary to a nationwide population-
based study of Taiwan patients with the severe sepsis conducted by Chang et al
124 
who 
observed that diabetes status does not influence the subsequent outcome with respect to 
hospital mortality or length of hospital stay. A similar observation was found by  Esper  
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et al 
5
 and they have observed that the diabetic patients are at increased risk for 
developing sepsis and the diabetic status does not influence the outcome of patients with 
sepsis. Though patients categorised as sepsis were higher in number as compared to those 
with severe sepsis and septic shock, there was an expected high mortality among patients 
with severe sepsis (12. 5%) and septic shock.(81.5%).  
Among the subjects studied, there was relatively increased number of patients who 
were dependent on inotropic support during admission. And those patients who were 
dependent on inotropic support showed a very high mortality rate. The survivors also had 
an increased duration of hospital stay.  Vance Beck et al
125
 observed that delayed 
initiation of vasopressor or inotropic medications in patients with septic shock is 
associated with increased organ failure risk and decreased survival outcome. From our 
study we could not come to a conclusion on the basis of the timing of initiation of 
vasopressor, inotropic agents and the outcome because of the major limitation being that, 
we could not risk delaying the initiation of inotropic agents in patients with the refractory 
septic shock who did not improve in spite of adequate fluid resuscitation. Yet it would be 
wise to understand that administration of vasopressors/ inotropic agents should not be 
delayed in patients with septic shock.  
The SOFA score was calculated with the available laboratory parameters during 
admission. The SOFA scores during admission correlated well with the outcome of the 
patients. Those patients with scores less than 5 had a better survival rate and   short 
duration of hospital stay. Those patients with the SOFA scores above 10 had a high 
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mortality rate. In the survivors group, SOFA scores more than 10 during admission had a 
prolonged duration of hospital stay and also developed complications. These patients 
needed vigorous intervention compared to those with a SOFA score of less than 10 
during admission. 
RDW is a quantitative measure of anisocytosis, the variability in size of the 
circulating erythrocytes. In the past RDW usually had been used for the differential 
diagnosis of iron-deficiency anaemia and acute appendicitis
83, 126
. In recent years, RDW 
has been demonstrated to predict mortality and other outcome in septic and septic shock 
in aged adults
90
 
In our study, the mean red cell distribution width on the day of presenting the 
illness was significantly higher in non survivors than survivors. Those patients who had a 
high red cell distribution width during admission were associated with poor survival. 
These patients also developed associated complications like acute kidney injury, 
coagulopathy, encephalopathy. Red cell distribution width was highest among patients 
with septic shock followed by severe sepsis and with sepsis (Mean 18.06; 16.73; 15.92). 
These parameters showed strong statistically significant correlation of red cell 
distribution width with the severity of sepsis. Based on the  changes in red cell 
distribution width during admission, after 72 hours  and after 7  days  it was evident 
that  majority of the study subjects in the survival group had a mean RDW of 16.22  at 
admission,15.94  after 72 hours and 15.79  after 7 days. In the non survivors group, the 
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red cell distribution width was 19.08 during admission, 18.93 after 72 hours, and 18.87 
after 7 days. From this we might conclude that the increase in red cell distribution width 
at admission in septic patients is associated with a significant increase in death 
outcome.  No statistical significant conclusion could be made among these group as far as 
change in red cell distribution width from baseline to 72 hours and after 7 days of 
hospitalization is concerned. This result correlates with the study of Mahmood et al.,
84 
in 
which RDW greater than 16 was concluded to be associated with increase in  severity of 
illness. In another study by Jo YH et al.,
 127
 RDW was significantly higher in non-
survivors than in survivors. Red Cell Distribution Width is an indicator which can vary in 
sepsis under the influence of TNF-α, IFN-δ, IL-1β, IL-6, the pro inflammatory cytokines 
which are released during the inflammatory process.
87
 These cytokines cause inefficient 
erythropoiesis resulting in structural and functional changes of erythrocytes with volume 
variation. This may be accounted for an increased value of RDW.  
NLCR reflects the systemic inflammatory response that accompanies chronic 
disease that might also be influenced by systemic infections, atherosclerosis, 
hypertension, chronic renal disease and diabetics.  A more recent study showed that an 
initial value of NLCR over 10 could be correlated with an unfavorable prognosis as 
assessed by the number of SIRS criteria, the presence of organ failure or septic metastasis 
at the time of admission
100
. In our study also the NLCR values were high at admission 
Our study showed that septic patients with NLCR value greater than 14 had 50 times 
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more risk of death than those with NLCR less than 14 and RDW>18 had 162 times more 
risk than septic patients with RDW< 18, at 28 days.  
In sepsis patients when NLCR was cross matched with SOFA score, there was a 
strong and positive correlation shown in a similar way as RDW correlates with SOFA 
score at admission. Thus it may be concluded that RDW and NLCR can be used as 
prognostic markers of sepsis, severe sepsis and septic shock and also to predict the 
outcome. 
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CONCLUSION 
In our study, the efficiency of RDW along with NLCR as biomarkers of sepsis, 
severe sepsis and septic shock has been made and the correlation of the SOFA score 
with RDW and NLCR in predicting the outcome of patients has been studied. In 
sepsis patients when SOFA score was cross matched with RDW and NLCR separately 
the increase in their values strongly and positively correlated with increase in SOFA 
score, thus elucidating the usefulness of RDW and NLCR as prognostic markers in the 
study of severity of sepsis and the outcome. However, there are certain limitations of 
the study. 
1. Since both RDW and NLCR levels are affected by many conditions, RDW 
and NLCR levels without other inflammatory indicators such as C-reactive protein, 
gamma-glutamyl transferase and albumin, may not give exact information about 
patients’ inflammatory status.  
2. Only the circulating neutrophil and lymphocyte counts were analyzed but the 
different subpopulations of the lymphocytes had not been explored. 
3. Patients` underlying diseases could alter the NLCR levels. Age and 
comorbidities are associated with the severity of sepsis and mortality. Genuine report 
of co morbidity could not be acquired from the patients.  
4. The study is a prospective observational study in a single institution in a 
short duration with less sample size of 85. For validation of the results, the sample 
size should be large.  
5. The time elapsed between the blood sampling and the measuring of RDW 
may significantly affect the RDW levels. Intra-day cell count variations also may be 
considered. All these necessitate future prospective clinical research. 
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SUMMARY 
 
A study on establishing the role of RDW and NLCR as biomarkers for the early 
detection of sepsis, severe sepsis and septic shock and in prediction of outcome was 
conducted. 
A total of 85 subjects meeting the inclusion and exclusion criteria and diagnosed 
with mild sepsis, severe sepsis and septic shock were selected. 
After a thorough clinical examination, blood sampling was done for all the 
subjects, within 3 hours of presenting the illness. The values of RDW and NLCR were 
studied on the day of admission, after 72 hours and after 7 days.  
Statistical studies were done by SPSS software and analysed by unpaired t test, 
chi-square test and Pearson’s  correlation coefficient.  
After analysis, we found that in patients of severe sepsis and septic shock class, in 
survivor and non-survivor group, significant elevation of RDW and NLCR was found. 
The cut off values of RDW and NLCR in predicting the mortality in 95% confidential 
interval were calculated. There was a good correlation of SOFA score with NLCR and 
RDW in predicting the 28 days outcome. 
The study revealed that RDW and NLR can be used as potential markers for early 
detection of severe sepsis and septic shock and in predicting the outcome. 
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Maheshwari 
35 F 0 AB I 100 60 2 8.5 16.2 7.8 15.8 4.9 15.8 Nil No NI W 8 R 
2 
 
Abdul Rehman 
65 M 1,2 RT  III 60 ? 12 14.6 18.8 12.2 18.4 xxx xxx ARDS,Enc,T Yes Gm-ve B ICU 4 NS 
3 
 
Susila 
58 F 2 UT I 140 80 2 8 15.8 6.6 15.6 4.2 15.8 Nil No Gm-ve B W 9 R 
4 
 
Chandra 
60 F 1 UT II 80 60 5 10.1 16.2 7.7 16 4.8 14.9 AKI No Gm-ve B ICU 9 R 
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Janarthanan 
60 M 0 ST I 100 70 1 8.4 16 7.7 15.8 5.1 15.2 Nil No Gm+ve B W 8 R 
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Mani 
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Rasathi 
56 F 1 ST II 80 50 3 8.8 16.2 7.8 15.9 5.1 15.4 T No NI ICU 10 R 
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Subathra 
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Balaraman 
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12 
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Yasodha 
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Rama Sri 
19 F 0 CNS III ? ? 12 13 19.4 13.2 19.2 xxx xxx Enc,MA Yes NI ICU 5 NS 
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Manivannan 
52 M 0 RT III 70 30 6 10 16.2 9.8 16.2 8.4 16 T,MA 
Yes Gm--ve B ICU 13 R 
20 
 
Kannammal 
65 F 1,5 UT II 80 50 3 9.6 16 9.2 16 8.2 15.6 T No Gm-ve B ICU 10 R 
21 
 
Saravanan 
50 M 0 AB I 140 90 1 9.8 16.2 8.8 16.2 7.4 15.8 Nil No NI W 9 R 
22 
 
Ramamurthy 
62 M 1 ST III 70 40 9 12.4 20.2 11 19.8 11 19.2 AKI,C,,MA Yes Gm+ve B ICU 7 NS 
23 
 
Subramanian 
35 M 0 BS I 110 70 0 8.1 15.4 6.9 15.2 3.8 15.2 Nil 
No Gm-ve B 
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7 R 
24 
 
Vijayakumar 
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Sathyamurthy 
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Raja 
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8 R 
27 
 
Krishnamoorthy 
50 M 0 RT I 90 60 2 8.6 15.8 6.2 15.2 3.8 15.2 Nil 
No Gm-ve B 
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9 R 
28 
 
Saraswathy 
65 F 1,3,5 AB III 60 ? 11 13.7 20.2 13.6 19.2 11 19 J, AKI , MA,,Enc Yes Anaerobe ICU 7 NS 
29 
 
Janaki 
65 F 0 RT I 90 60 2 8.6 16.8 8 15.8 7 15.4 Nil 
No NI 
W 
14 R 
30 
 
Thangaraj 
60 M 0 AB I 90 60 2 9.1 16 8.5 15.22 5 15.2 J 
No NI 
W 
8 R 
31 
 
Ganesan 
52 M 1 UT III ? ? 11 12.8 19 xxx xxx xxx xxx AKI,MA,,Enc Yes NI ICU 0 NS 
32 
 
Murugan 
40 M 0 CNS III 70 40 7 11.6 17.2 8.2 16.2 5.2 16.2 Enc,MA 
Yes Gm-ve B ICU 15 R 
33 
 
Jeyakumar 
19 M 0 BS I 90 60 1 8 16.2 7.8 15.8 4 15.2 Nil No Gm-ve B W 9 R 
34 
 
Kasthuri 
82 F 1 ST III  60 ? 11 12.2 20.2 11 18.4 xxx xxx AKI,C,Enc Yes Gm+ve B ICU 4 NS 
35 
 
Vanaroja 
70 F 1,2 UT II 70 ? 8 14 18.6 10 18.8 10 19.4 AKI,MA,Enc 
Yes Gm-ve B ICU 7 NS 
36 
 
Ramesh 
35 M 0 RT I 90 60 2 9.1 15.4 6 15.2 3.8 15.2 Nil No NI 
W 
7 R 
37 
 
Janaki 
62 F 1,2,6 ST I 150 70 2 7.6 15.6 8.2 15.4 5 15.4 T No Gm+ve B 
W 
8 R 
38 
 
Liyakath Ali 
68 M 2,6 RT I 140 80 2 7.5 15.2 6.2 15.2 4.2 15.2 Nil No Gm+ve B 
W 
9 R 
39 
 
Ramesh 
39 M 0 BS I 110 60 1 6.4 15.6 6 15.2 3.6 15.4 J No Gm-ve B 
W 
7 R 
40 
 
Tamilselvi 
60 F 2 UT III 70 40 6 12.3 17.4 7 16.4 5 16 AKI,MA,,Enc, Yes Gm-ve B ICU 9 R 
41 
 
Senthilkumar 
42 M 0 AB I 100 70 2 8.6 15.8 6.2 15.2 4.1 15.2 T No NI W 7 R 
42 
 
Janakiraman 
66 M 1 ST III 70 ? 11 9.8 18.8 9.1 18 6.4 18 AKI,MA,,Enc 
Yes Gm+ve B ICU 14 R 
43 
 
Fathima Bee 
70 F 1,7 RT III 70 ? 11 12.1 19.4 10.4 19 xxx xxx ARDS,Enc,C Yes Gm+ve B ICU 5 NS 
44 
 
Pandiyan 
40 M 0 RT I 90 60 1 9.1 15 4.2 15 4 15.2 Nil No NI W 8 R 
45 
 
Maimoon Bee 
56 F 1 UT  III 70 40 8 11.4 16 11.2 16.2 7 16.4 AKI,MA,Enc, Yes Gm-ve B ICU 20 R 
46 
 
Kaliyaperumal 
58 M 4 RT I 90 60 4 9.2 15.6 8.2 15.4 6.2 15.4 T No NI 
W 
14 R 
47 
 
Paunammal 
36 F 0 UT II 100 70 5 10.2 15.8 6.5 15.6 4.8 15.4 AKI,J,MA No Gm-ve B 
W 
13 R 
48 
 
PonRaj 
52 M 2,5 AB I 120 70 1 7.9 15 6 14.8 3.9 14.8 Nil No NI 
W 
9 R 
49 
 
Vasudevan 
60 M 4 RT I 110 70 3 7 15.4 7.6 15.2 5 15.2 T No Gm+ve B 
W 
8 R 
50 
 
Vinothini 
35 F 0 ST II 70 40 7 9.8 16.2 11.2 16.2 8.2 16 MA,T,C 
Yes Fungus ICU 18 R 
51 
 
Manoharan 
58 M 0 UT III 80 60 8 11.2 17.2 9.8 16.6 6.2 16.6 AKI,MA,Enc 
Yes Gm-ve B ICU 12 R 
52 
 
Ayyavu 
70 M 1,2 RT III ? ? 12 15.7 19.2 11.4 19 xxx xxx ARDS,Enc,C 
Yes NI ICU 4 NS 
53 
 
Janaki 
68 F 1 UT III ? ? 11 13.5 20.2 xxx xxx xxx xxx AKI,Enc,MA 
Yes Gm-ve B ICU 0 NS 
54 
 
BegumJaan 
62 F 1,3 ST I 90 60 4 9.4 16.8 9 16.2 5.8 16.2 AKI 
No Gm+ve B 
W 
9 R 
55 
 
Nishanthini 
37 F 0 AB I 100 70 3 9.8 16.2 7.2 16.2 5.9 16.2 T 
No Gm-ve B 
W 
8 R 
56 
 
Gayathri 
21 F 0 RT I 100 60 0 7.8 15.6 7.2 15.4 6.2 15.4 Nil 
No NI 
W 
7 R 
57 
 
Kanniyammal 
58 F 2,3 IAT I 90 60 6 7.4 15.2 8.2 15.2 4 15.2 MA, AKI 
No Gm+ve B ICU 12 R 
58 
 
Chinnarasu 
56 M 1 UT I 100 70 2 6.2 15.6 4.4 15.6 3.8 15.2 Nil 
No Gm-ve B W 8 R 
59 
 
Vinodhini 
32 F 0 BS II 90 60 5 8.1 16.2 5.4 16.2 4.4 16 J,T, ,MA 
No Gm-ve B ICU 9 R 
60 
 
Ponraj 
65 M 1 ST III 70 40 11 12.4 17 7.2 16.8 4.8 16.6 AKI,MA,Enc Yes Gm+ve B ICU 22 R 
61 
 
Murugan 
48 M 0 BS I 110 60 2 8.6 16.4 6 16.2 4.4 16.2 Nil No Gm-ve B 
W 
8 R 
62 
 
Saravanan 
45 M 0 BS I 100 70 2 9 16 6.4 16.2 5.1 16.2 Nil No Gm-ve B 
W 
8 R 
63 
 
Chandra 
65 F 1,2 UT I 120 90 2 7.8 15.6 5.2 15.6 4 15.2 Nil No Gm-ve B 
W 
9 R 
64 
 
Sagaya Mary 
70 F 1 ST III ? ? 13 15.2 18.8 xxx xxx xxx xxx Enc,MA, J,C Yes Gm+ve B ICU 0 NS 
65 
 
Meghala 
66 F 0 CNS II 90 60 6 9.6 17.2 6.2 16.2 5.4 16.2 Enc,T 
No NI ICU 14 R 
66 
 
Narayanan 
67 M 4 RT I 100 70 4 7.4 16 4.2 16 3.6 15.4 
T 
No 
Gm+ve B W 8 R 
67 
 
Kuppammal 
80 F 1,2 RT II ? ? 9 11.5 16.4 xxx xxx xxx xxx ARDS,Enc 
Yes NI ICU 1 NS 
68 
 
Abdul lateef 
62 M 0 RT II 70 40 7 11.8 16.8 6.6 16.2 5.2 16.2 T,AKI,MA 
Yes Gm-ve B ICU 14 R 
69 
 
Ramasubbu 
70 M 1,5 UT III 70 40 6 12.8 19.2 8.4 19 7.4 17.2 T, AKI 
Yes Gm-ve B ICU 15 R 
70 
 
Janaki 
66 F 1,7 ST II 80 50 6 12.6 19.4 13.2 19.2 10.4 19.2 T,C,MA 
Yes Gm+ve B ICU 22 R 
71 
 
Maheshwari 
48 F 0 BS II 80 60 5 9.4 16.6 9.8 16.2 6.2 15.4 J,MA,T 
No Gm-ve B ICU 13 R 
72 
 
Shanmugam 
61 M 2 BS I 90 60 2 9.8 16.4 7.6 16.4 4.1 16.2 T 
No Gm-ve B 
W 
10 R 
73 
 
Mani 
60 M 0 UT III 80 40 4 10.4 18.2 8.2 18 5.8 17 AKI 
No Gm-ve B 
W 
11 R 
74 
 
Kadar Basha 
64 M 1,3 UT III 60 ? 14 14.6 18.8 13.4 19 xxx xxx AKI,MA,Enc Yes Gm-ve B ICU 4 NS 
75 
 
Irudhayaraj 
57 M 0 RT I 110 80 0 8.2 16.2 8.4 16.2 4.2 16 Nil 
No Gm+ve B W 8 R 
76 
 
Vennila 
65 F 1 ST III 70 40 5 9.8 16.6 8 16.4 6.1 16.2 T,C 
No Gm+ve B ICU 13 R 
77 
 
Senbagam 
43 F 0 BS I 110 70 0 7 15.8 5.4 15.6 3.6 15.6 Nil 
No Gm-ve B W 7 R 
78 
 
Neela 
65 F 2,7 RT III 70 40 7 9.2 16.2 7.1 16.2 5.2 16 ARDS Yes Gm+ve  B ICU 12 R 
79 
 
Kannathal 
56 F 2 AB I 120 70 1 8.1 15.4 4.8 15.4 4.2 15.2 Nil 
No NI W 9 R 
80 
 
Davidraj 
55 M 0 AB I 90 60 2 7.8 15 5.8 15 4.3 15.2 Nil 
No NI W 9 R 
81 
 
Banumathi 
65 F 1 AB III ? ? 12 12.8 18.8 xxx xxx xxx xxx J, AKI,MA 
Yes NI ICU 0 NS 
82 
 
Kandasamy 
72 M 2,8 RT I 70 ? 9 10.6 17.4 11.4 17.6 xxx xxx ARDS,Enc 
Yes Gm+ve B ICU 4 NS 
83 
 
Santharam 
54 M 0 RT I 100 70 2 8.4 16.2 6.4 16.2 5.8 15.8 Nil 
No NI 
W 
10 R 
84 
 
Senthil 
60 M 0 UT I 90 60 1 8.8 16.4 6.2 16 4.2 16.2 Nil 
No Gm-ve B 
W 
8 R 
85 
 
Yesudas 
65 M 2 ST I 120 70 0 7.4 16 5.1 16 4.8 16.2 Nil 
No Gm+ve B 
W 
7 R 
 
 
 
 
LIST OF ABBREVIATIONS 
RDW Red blood cell distribution width 
NLCR/       NLR Neutrophil to lymphocyte count ratio 
PDW Platelet distribution width 
MPV Mean Platelet Volume 
APACHE Acute Physiology and Chronic Health Evaluation 
SOFA Sequential Organ Failure Assessment 
SIRS Systemic inflammatory response syndrome 
PCT Procalcitonin 
CRP C-reactive protein 
ICU Intensive Care Unit 
MEDS Mortality in Emergency Department Sepsis 
CVS Cardio Vascular System 
CNS Central Nervous System 
RS Respiratory system 
DM Diabetes Mellitus 
SHT Systemic Hypertension 
CKD Chronic Kidney Disease 
COPD Chronic Obstructive Pulmonary Disease 
CCF Congestive Cardiac Failure 
IHD Ischemic Heart Disease 
 

